Team 2: Cardiovascular Structural Diseases

Group leaders: Catherine BOILEAU & Guillaume JONDEAU

LdVAortic root and aortic valves share numerous common structural, physiological, genetic, and pathophysiologic features. Aortic root and heart valves are vascular tissues highly enriched with fibrillar insoluble extracellular matrix components, including proteoglycans, elastin, and collagen — in situ synthesized by stromal cells : myofibroblasts in valves, smooth muscle cells in aorta. Both tissues support the elevated mechanical stress generated by hemodynamics in the human body, including physiological vortices in the valsalva sinus during diastole (depicted by Leornardo Da Vinci 500 years ago; figure) and the impact of the systolic ejected flow on the aortic root. As a consequence, aortic root and valves pathologies share common etiologies including monogenic heritable diseases, such as Marfan syndrome, which is recognized as a pathogenic determinant of aneurysms and dissections of the ascending aorta, but also of valve structural abnormality and dysfunction. In parallel, bicuspid aortic valve, a highly frequent congenital anomaly, is an important anatomic risk factor for development of aortic valve stenosis but also of aneurysms and/or dissections of the aortic root. Structural diseases of aortic root, aneurysms and dissections, and heart valves, stenosis and calcifications, share the common histological feature of areas of mucoid degeneration, determined by genomic/ hemodynamic microenvironment in both these tissues. For example, aneurysms preferentially develop in valsalva sinus in response to Marfan mutations, in relation to physiological vortices, whereas aneurysms develop in the aortic root in bicuspids, in relation to the change of the aortic ring geometry (oval versus round).

Our project is to pursue the discovery of new genes and of genetic modifiers involved in aortic root and valve diseases in human, to decipher the common and different pathophysiology of these diseases, to develop new diagnostic (functional and molecular imaging) and interventional therapeutics and to decrypt the interactions between aortic valves and aortic root.

The new team 2 originated from Team 6 of U698 (C Boileau) with the addition for the valvular disease project of D Messika-Zeitoun, Alec Vahanian, B Iung – new members – and D Himbert (PH) and MP Jacob (DR2 CNRS) from previous teams 5 and 2, respectively.

Name
Position
Phone
Email
ABI-FADEL MariannePU01.44.25.75.28marianne.abi-fadel@inserm.fr
ABOU KHLIL YaraMaster 2
ARNAUD PaulineAHU01.40.25.85.55 / 01.40.25.75.28pauline.arnaud@aphp.fr
AUBART MélodiePH01.40.25.75.28melodie.aubart@inserm.fr
BENNARROCH LouiseDoctorant01.40.25.75.28louise.benarroch@inserm.fr
BOILEAU CatherinePU-PH01.40.25.75.21 / 01.49.05.55.30/31catherine.boileau@inserm.fr
BOISSEAU WilliamMaster 2 AR boisseau.william@hotmail.fr
BOULETI ClairePH claire.bouleti@aphp.fr
DARMON ArthurMaster 2
EL KHOURY PetraPost Doc petra_khoury@hotmail.com
ELBITAR SandyDoctorant sandy.el-bitar@inserm.fr
ETIENNE HarryInterne h.etienne@hotmail.fr
GHALEB YoumnaDoctorant01.40.25.75.22youmna.ghaleb@etu.univ-paris-diderot.fr
GRANGE ThomasMaster 2
GROSS Marie-SylvieAI01.40.25.75.28marie-sylvie.gross@inserm.fr
HANNA NadinePH01.49.09.55.97nadine.hanna@aphp.fr
HIMBERT DominiquePH01.40.25.73.25dominique.himbert@aphp.fr
IUNG BernardPU-PH bernard.iung@aphp.fr
JACOB Marie-PauleDR01.40.25.86.17marie-paule.jacob-lenet@inserm.fr
JONDEAU GuillaumePU-PH01.40.25.68.10guillaume.jondeau@aphp.fr
MAMAN EstherMaster 2
MESSIKA-ZEITOUN DavidPHU01.40.25.73.25david.messika-zeitoun@gmail.com / david.messika-zeitoun@aphp.fr
MICHEL Jean-BaptisteDRE01.40.25.75.26jean-baptiste.michel@inserm.fr
MILLERON Olivier olivier.milleron-ext@aphp.fr
RABES Jean-PierreMCUPH01.49.09.55.97 / 01.40.25.75.28jean-pierre.rabes@aphp.fr / jean-pierre.rabes@inserm.fr
VAHANIAN AlecPU-PH alec.vahanian@aphp.fr
VARRET MathildeCR01.40.25.75.21mathilde.varret@inserm.fr

2017

1.
Aboulhosn J, Cabalka AK, Levi DS, Himbert D, Testa L, Latib A, Makkar RR, Boudjemline Y, Kim DW, Kefer J, Bleiziffer S, Kerst G, Dvir D, McElhinney DB. 2017. Transcatheter Valve-in-Ring Implantation for the Treatment of Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair. JACC: Cardiovascular interventions 10:53–63.
1.
Ailawadi G, Iung B. 2017. The TVT Registry: Collaboration Leading to Quality Control. Journal of the American College of Cardiology 69:1231–1233.
1.
Alfieri O, Vahanian A. 2017. The year in cardiology 2016: valvular heart disease. European Heart Journal 38:628–633.
1.
Andrikopoulou M, Vahanian SA, Chavez MR, Murphy J, Hanna N, Vintzileos AM. 2017. Improving the ultrasound detection of isolated fetal limb abnormalities. Journal of Maternal-Fetal & Neonatal Medicine 30:46–49.
1.
Banovic M, Bartunek J, Nikolic SD, Vukcevic V, Aleksandric S, Iung B. 2017. Percutaneous treatment of aortic valve disease: contemporary overview and future trends. Current Pharmaceutical Design.
1.
Bouleti C, Chauvet M, Franchineau G, Himbert D, Iung B, Alos B, Brochet E, Urena M, Ghodbane W, Ou P, Provenchere S, Nataf P, Vahanian A. 2017. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome. European Journal of Cardio-Thoracic Surgery 51:80–88.
1.
Cambau E, Durand-Zaleski I, Bretagne S, Buisson CB, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S, team E study. 2017. Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial. Intensive Care Medicine.
1.
Capretti G, Urena M, Himbert D, Ghodbane W, Gardy Verdonk C, Goublaire C, Alkhoder S, Raffoul R, Carrasco JL, Laredo M, Nataf P, Vahanian A. 2017. Suprasternal brachiocephalic approach as an alternative route for transcatheter aortic valve implantation: a single-centre experience. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 12:e1849–e1856.
1.
Coquand-Gandit M, Jacob M-P, Fhayli W, Romero B, Georgieva M, Bouillot S, Estève E, Andrieu J-P, Brasseur S, Bouyon S, Garcia-Honduvilla N, Huber P, Buján J, Atanasova M, Faury G. 2017. Chronic Treatment with Minoxidil Induces Elastic Fiber Neosynthesis and Functional Improvement in the Aorta of Aged Mice. Rejuvenation Res.
1.
Coscas R, Bensussan M, Jacob M-P, Louedec L, Massy Z, Sadoine J, Daudon M, Chaussain C, Bazin D, Michel J-B. 2017. Free DNA precipitates calcium phosphate apatite crystals in the arterial wall in vivo. Atherosclerosis 259:60–67.
1.
Debry N, Maréchaux S, Rusinaru D, Peltier M, Messika-Zeitoun D, Menet A, Tribouilloy C. 2017. Prognostic significance of left ventricular concentric remodelling in patients with aortic stenosis. Archives of Cardiovascular Diseases 110:26–34.
1.
Derkx S, Nguyen V, Cimadevilla C, Verdonk C, Lepage L, Raffoul R, Nataf P, Vahanian A, Messika-Zeitoun D. 2017. Anatomical features of acute mitral valve repair dysfunction: Additional value of three-dimensional echocardiography. Archives of Cardiovascular Diseases 110:196–201.
1.
Farber AJ, Suarez K, Slicker K, Patel CD, Pope B, Kowal R, Michel JB. 2017. Frequency of Troponin Testing in Inpatient Versus Outpatient Settings. American Journal of Cardiology 119:1153–1155.
1.
Fernandez-García CE, Burillo E, Lindholt JS, Martinez-Lopez D, Pilely K, Mazzeo C, Michel JB, Egido J, Garred P, Blanco-Colio LM, Martin-Ventura JL. 2017. Association of ficolin-3 with abdominal aortic aneurysm presence and progression. Journal of thrombosis and haemostasis 15:575–585.
1.
Frey N, Steeds RP, Serra A, Schulz E, Baldus S, Lutz M, Pohlmann C, Kurucova J, Bramlage P, Messika-Zeitoun D. 2017. Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE). BMC cardiovascular disorders 17:5.
1.
Garcia R, Labarre Q, Degand B, Ingrand P, Le Gal F, Bonnet B, Delaubier A, Guillou C, Gellen B, Coisne D, Bouleti C, Christiaens L. 2017. Apical left ventricular myocardial dysfunction is an early feature of cardiac involvement in myotonic dystrophy type 1. Echocardiography 34:184–190.
1.
Guerrero M, Wang DD, Himbert D, Urena M, Pursnani A, Kaddissi G, Iyer V, Salinger M, Chakravarty T, Greenbaum A, Makkar R, Vahanian A, Feldman T, O’Neill W. 2017. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification. Catheterization and Cardiovascular Interventions.
1.
Ho-Tin-Noé B, Vo S, Bayles R, Ferrière S, Ladjal H, Toumi S, Deschildre C, Ollivier V, Michel J-B. 2017. Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma. Journal of Pathology 241:671–682.
1.
Iung B. 2017. The need for a continuing awareness of the quality of anticoagulant therapy in patients with mechanical prostheses. Heart (British Cardiac Society) 103:179–180.
1.
Iung B, Rouzet F, Brochet E, Duval X. 2017. Cardiac Imaging of Infective Endocarditis, Echo and Beyond. Current Infectious Disease Reports 19:8.
1.
Jullien V, Azoulay E, Schwebel C, Le Saux T, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet J-L, Bruneel F, Cour M, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou J-C, Foucrier A, Allaouchiche B, Das V, Gangneux J-P, Ruckly S, Wolff M, Timsit J-F, Group ETS. 2017. Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation. Journal of Antimicrobial Chemotherapy 72:181–189.
1.
Maël H, Audrey B, Evelyne C-B, Pierre-Yves D, Kaddour C, Gilles S, Arnaud P. 2017. BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib. Annals of Hematology 96:335–336.
1.
Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WSME, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA, Investigators A. 2017. Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer. New England Journal of Medicine 376:629–640.
1.
Moubarak G, Bouzeman A, de Geyer d’Orth T, Bouleti C, Beuzelin C, Cazeau S. 2017. Variability in obstructive sleep apnea: Analysis of pacemaker-detected respiratory disturbances. Heart Rhythm 14:359–364.
1.
Nguyen V, Cimadevilla C, Arangalage D, Dehoux M, Codogno I, Duval X, Tubiana S, Vahanian A, Messika-Zeitoun D. 2017. Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis. International Journal of Cardiology 230:371–377.
1.
Olivier A, Girerd N, Michel JB, Ketelslegers JM, Fay R, Vincent J, Bramlage P, Pitt B, Zannad F, Rossignol P, Investigators E. 2017. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. International Journal of Cardiology.
1.
Seidah NG, Abifadel M, Prost S, Boileau C, Prat A. 2017. The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9. Pharmacological Reviews 69:33–52.
1.
Sénémaud J, Caligiuri G, Etienne H, Delbosc S, Michel J-B, Coscas R. 2017. Translational Relevance and Recent Advances of Animal Models of Abdominal Aortic Aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology 37:401–410.
1.
Terzian Z, Gasser TC, Blackwell F, Hyafil F, Louedec L, Deschildre C, Ghodbane W, Dorent R, Nicoletti A, Morvan M, Nejjari M, Feldman L, Pavon-Djavid G, Michel J-B. 2017. Peristrut microhemorrhages: a possible cause of in-stent neoatherosclerosis? Cardiovascular Pathology 26:30–38.
1.
Terzian Z, Urena M, Himbert D, Gardy-Verdonk C, Iung B, Bouleti C, Brochet E, Ghodbane W, Depoix J-P, Nataf P, Vahanian A. 2017. Causes and temporal trends in procedural deaths after transcatheter aortic valve implantation. Archives of Cardiovascular Diseases.
1.
Vahanian A, Juliard JM, Brochet E. 2017. When surgery is not an option: is there a clinical need for transcatheter tricuspid valve therapies? Minerva Cardioangiologica.
1.
Waldmann V, Milleron O, Iung B, Messika-Zeitoun D, Lepage L, Ghodbane W, Brochet E, Vahanian A, Nataf P, Jondeau G. 2017. Is Transesophageal Echocardiography Needed before Hospital Discharge in Patients after Bentall Surgery? Journal of the American Society of Echocardiography 30:52–58.
1.
Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann F-J, Tarantini G, Zamarano JL, Vahanian A. 2017. SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve. Circulation 135:1123–1132.

2016

1.
Abdelghani M, Soliman OII, Schultz C, Vahanian A, Serruys PW. 2016. Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal. European Heart Journal 37:2627–2644.
1.
Antona D, Kossorotoff M, Schuffenecker I, Mirand A, Leruez-Ville M, Bassi C, Aubart M, Moulin F, Lévy-Bruhl D, Henquell C, Lina B, Desguerre I. 2016. Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016. Euro Surveillance 21.
1.
Arangalage D, Lepage L, Faille D, Cimadevilla C, Dilly M-P, Papy E, Alhenc-Gelas M, Ghodbane W, Nataf P, Iung B, Steg PG, Vahanian A, Ajzenberg N, Messika-Zeitoun D. 2016. Presentation, management and outcome of heparin-induced thrombocytopenia after valvular heart surgery. European Journal of Cardio-Thoracic Surgery 50:1132–1138.
1.
Arangalage D, Nguyen V, Robert T, Melissopoulou M, Mathieu T, Estellat C, Codogno I, Huart V, Duval X, Cimadevilla C, Vahanian A, Dehoux M, Messika-Zeitoun D. 2016. Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis. Heart (British Cardiac Society) 102:862–868.
1.
Armoiry X, Obadia J-F, Iung B, Polazzi S, Duclos A. 2016. Clinical outcomes and direct costs after transcatheter aortic valve implantation in French centres: a longitudinal study of 1332 patients using a national database. Interactive Cardiovascular and Thoracic Surgery 23:883–888.
1.
Arsalan M, Agricola E, Alfieri O, Baldus S, Colombo A, Filardo G, Hammerstingl C, Huntgeburth M, Kreidel F, Kuck K-H, LaCanna G, Messika-Zeitoun D, Maisano F, Nickenig G, Pollock BD, Roberts BJ, Vahanian A, Grayburn PA. 2016. Effect of Transcatheter Mitral Annuloplasty With the Cardioband Device on 3-Dimensional Geometry of the Mitral Annulus. American Journal of Cardiology 118:744–749.
1.
Aubart M, Ou P, Elie C, Canniffe C, Kutty S, Delos V, Graffigne C, de Montalembert M, Brousse V. 2016. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major. Journal of Pediatric Hematology/Oncology 38:497–502.
1.
Badoz M, Arrigo M, Iung B, Amioglu G, Yilmaz MB, Meneveau N, Sadoune M, Brunette A, Mebazaa A, Seronde M-F. 2016. Role of cardiovascular biomarkers for the assessment of mitral stenosis and its complications. European Journal of Internal Medicine 34:58–62.
1.
Banovic M, Iung B, Bartunek J, Asanin M, Beleslin B, Biocina B, Casselman F, da Costa M, Deja M, Gasparovic H, Kala P, Labrousse L, Loncar Z, Marinkovic J, Nedeljkovic I, Nedeljkovic M, Nemec P, Nikolic SD, Pencina M, Penicka M, Ristic A, Sharif F, Van Camp G, Vanderheyden M, Wojakowski W, Putnik S. 2016. Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial. American Heart Journal 174:147–153.
1.
Banovic M, Iung B, Bartunek J, Penicka M, van Camp G, Nikolic S, Putnik S. 2016. Response: Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in “the world of AVATAR.” American Heart Journal 178:e3–4.
1.
Beneit N, Fernández-García CE, Martín-Ventura JL, Perdomo L, Escribano Ó, Michel JB, García-Gómez G, Fernández S, Díaz-Castroverde S, Egido J, Gómez-Hernández A, Benito M. 2016. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis. Cardiovascular Diabetology 15:161.
1.
Boersma LVA, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, Pokushalov E, Kische S, Schmitz T, Stein KM, Bergmann MW, investigators E. 2016. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. European Heart Journal 37:2465–2474.
1.
Boukais K, Bayles R, Borges L de F, Louedec L, Boulaftali Y, Ho-Tin-Noé B, Arocas V, Bouton M-C, Michel J-B. 2016. Uptake of Plasmin-PN-1 Complexes in Early Human Atheroma. Frontiers in Physiology 7:273.
1.
Bouleti C, Amsallem M, Touati A, Himbert D, Iung B, Alos B, Brochet E, Urena M, Ghodbane W, Ou P, Dilly M-P, Nataf P, Vahanian A. 2016. Early and late outcomes after trans-catheter aortic valve implantation in patients with previous chest radiation. Heart (British Cardiac Society) 102:1044–1051.
1.
Bouleti C, Baudry G, Iung B, Arangalage D, Abtan J, Ducrocq G, Steg P-G, Vahanian A, Henry-Feugeas M-C, Pasi N, Chillon S, Pitocco F, Laissy J-P, Ou P. 2016. Usefulness of Late Iodine Enhancement on Spectral CT in Acute Myocarditis. JACC: Cardiovascular imaging.
1.
Bouleti C, Juliard J-M, Himbert D, Iung B, Brochet E, Urena M, Dilly M-P, Ou P, Nataf P, Vahanian A. 2016. Tricuspid valve and percutaneous approach: No longer the forgotten valve! Archives of Cardiovascular Diseases 109:55–66.
1.
Braquet P, Alla F, Cornu C, Goehringer F, Piroth L, Chirouze C, Revest M, Lechiche C, Duval X, Le Moing V, group V-A study. 2016. Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study. Clinical Microbiology and Infection 22:948.e1–948.e7.
1.
Brun A, Rangé H, Prouvost B, Meilhac O, Mazighi M, Amarenco P, Lesèche G, Bouchard P, Michel J-B. 2016. Intraplaque hemorrhage, a potential consequence of periodontal bacteria gathering in human carotid atherothrombosis. Bulletin du Groupement International pour la Recherche Scientifique en Stomatologie et Odontologie 53:e11.
1.
Burillo E, Jorge I, Martínez-López D, Camafeita E, Blanco-Colio LM, Trevisan-Herraz M, Ezkurdia I, Egido J, Michel J-B, Meilhac O, Vázquez J, Martin-Ventura JL. 2016. Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm. Scientific Reports 6:38477.
1.
Campbell OMR, Benova L, MacLeod D, Baggaley RF, Rodrigues LC, Hanson K, Powell-Jackson T, Penn-Kekana L, Polonsky R, Footman K, Vahanian A, Pereira SK, Santos AC, Filippi VGA, Lynch CA, Goodman C. 2016. Family planning, antenatal and delivery care: cross-sectional survey evidence on levels of coverage and inequalities by public and private sector in 57 low- and middle-income countries. Trop Med Int Health 21:486–503.
1.
Capretti G, Urena M, Himbert D, Brochet E, Goublaire C, Verdonk C, Carrasco JL, Ghodbane W, Messika-Zeitoun D, Iung B, Nataf P, Vahanian A. 2016. Valve Thrombosis After Transcatheter Mitral Valve Replacement. Journal of the American College of Cardiology 68:1814–1815.
1.
Cavallaro FL, Duclos D, Baggaley RF, Penn-Kekana L, Goodman C, Vahanian A, Santos AC, Bradley J, Paintain L, Gallien J, Gasparrini A, Hasselback L, Lynch CA. 2016. Taking stock: protocol for evaluating a family planning supply chain intervention in Senegal. Reprod Health 13:45.
1.
Chin CWL, Messika-Zeitoun D, Shah ASV, Lefevre G, Bailleul S, Yeung ENW, Koo M, Mirsadraee S, Mathieu T, Semple SI, Mills NL, Vahanian A, Newby DE, Dweck MR. 2016. A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis. European Heart Journal 37:713–723.
1.
Chopra H, Arangalage D, Bouleti C, Zarka S, Fayard F, Chillon S, Laissy J-P, Henry-Feugeas M-C, Steg P-G, Vahanian A, Ou P. 2016. Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. International Journal of Cardiology 212:63–69.
1.
Coffey S, Cairns BJ, Iung B. 2016. The modern epidemiology of heart valve disease. Heart (British Cardiac Society) 102:75–85.
1.
Collarino R, Vergeylen U, Emeraud C, Latournèrie G, Grall N, Mammeri H, Messika-Zeitoun D, Vallois D, Yazdanpanah Y, Lescure FX, Bleibtreu A. 2016. Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description. New Microbes New Infect 13:40–42.
1.
De Bonis M, Al-Attar N, Antunes M, Borger M, Casselman F, Falk V, Folliguet T, Iung B, Lancellotti P, Lentini S, Maisano F, Messika-Zeitoun D, Muneretto C, Pibarot P, Pierard L, Punjabi P, Rosenhek R, Suwalski P, Vahanian A, Wendler O, Prendergast B. 2016. Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. European Heart Journal 37:133–139.
1.
Deharo P, Urena M, Himbert D, Brochet E, Rouleau F, Pinaud F, Delepine S, Carrasco JL, Ghodbane W, Extramiana F, Ou P, Dilly MP, Messika-Zeitoun D, Iung B, Nataf P, Vahanian A. 2016. Bail-Out Alcohol Septal Ablation for Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement. JACC Cardiovascular interventions 9:e73–76.
1.
Delbosc S, Rouer M, Alsac J-M, Louedec L, Al Shoukr F, Rouzet F, Michel J-B, Meilhac O. 2016. High-density lipoprotein therapy inhibits Porphyromonas gingivalis-induced abdominal aortic aneurysm progression. Thrombosis and Haemostasis 115:789–799.
1.
Delbosc S, Rouer M, Alsac J-M, Louedec L, Philippe M, Meilhac O, Whatling C, Michel J-B. 2016. Elastase inhibitor AZD9668 treatment prevented progression of experimental abdominal aortic aneurysms. Journal of Vascular Surgery 63:486–492.e1.
1.
Fogli A, Chautard E, Vaurs-Barrière C, Pereira B, Müller-Barthélémy M, Court F, Biau J, Pinto AA, Kémény J-L, Khalil T, Karayan-Tapon L, Verrelle P, Costa BM, Arnaud P. 2016. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients’ survival. Carcinogenesis 37:169–176.
1.
Fragoso AC, Steyaert H, Arnaud P, Esposito C, Estevao-Costa J, Valla J-S. 2016. Minimal access surgery in the management of pediatric urolithiasis. Transl Pediatr 5:262–265.
1.
Furuta A, Lellouche N, Mouillet G, Dhanjal T, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Dubois-Rande J-L, Teiger E. 2016. Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy. International Journal of Cardiology 210:72–79.
1.
Gaede L, Di Bartolomeo R, van der Kley F, Elsässer A, Iung B, Möllmann H. 2016. Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 12:883–889.
1.
Galat A, Guellich A, Bodez D, Slama M, Dijos M, Zeitoun DM, Milleron O, Attias D, Dubois-Randé J-L, Mohty D, Audureau E, Teiger E, Rosso J, Monin J-L, Damy T. 2016. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? European Heart Journal 37:3525–3531.
1.
Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barberà J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol Ç, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GYH, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel M-P, Rigau D, Rosenkranz S, Völler H, Luis Zamorano J. 2016. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Heart Journal 37:67–119.
1.
Gilard M, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Tchetche D, Carrié D, Himbert D, Albat B, Cribier A, Sudre A, Blanchard D, Rioufol G, Collet F, Houel R, Dos Santos P, Meneveau N, Ghostine S, Manigold T, Guyon P, Grisoli D, Le Breton H, Delpine S, Didier R, Favereau X, Souteyrand G, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel J-P, Bourlon F, Bertrand B, Laskar M, Iung B, Investigators F. 2016. Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry. Journal of the American College of Cardiology 68:1637–1647.
1.
Gilard M, Schlüter M, Snow TM, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Alegria Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C. 2016. The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 12:79–87.
1.
Gomez I, Ozen G, Deschildre C, Amgoud Y, Boubaya L, Gorenne I, Benyahia C, Roger T, Lesèche G, Galardon E, Topal G, Jacob M-P, Longrois D, Norel X. 2016. Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity. PloS One 11:e0158421.
1.
Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, Greenbaum A, Mahadevan VS, Holzhey D, O’Hair D, Dumonteil N, Rodés-Cabau J, Piazza N, Palma JH, DeLago A, Ferrari E, Witkowski A, Wendler O, Kornowski R, Martinez-Clark P, Ciaburri D, Shemin R, Alnasser S, McAllister D, Bena M, Kerendi F, Pavlides G, Sobrinho JJ, Attizzani GF, George I, Nickenig G, Fassa A-A, Cribier A, Bapat V, Feldman T, Rihal C, Vahanian A, Webb J, O’Neill W. 2016. Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry. JACC Cardiovascular interventions 9:1361–1371.
1.
Guerrero M, Urena M, Pursnani A, Wang DD, Vahanian A, O’Neill W, Feldman T, Himbert D. 2016. Balloon expandable transcatheter heart valves for native mitral valve disease with severe mitral annular calcification. Journal of Cardiovascular Surgery 57:401–409.
1.
Génier F, Arnaud P. 2016. Dendropaemon Perty, 1830: taxonomy, systematics and phylogeny of the morphologically most derived phanaeine genus (Coleoptera: Scarabaeidae, Scarabaeinae, Phanaeini). Zootaxa 4099:1–125.
1.
Habib G, Lancellotti P, Iung B. 2016. 2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease. Heart (British Cardiac Society) 102:992–994.
1.
Hasenfuß G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, Malek F, Van der Heyden J, Lang I, Petrie MC, Cleland JGF, Leon M, Kaye DM, investigators RL-H study. 2016. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet 387:1298–1304.
1.
Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V, Poyart C, Alla F, Cambau E, Tattevin P, Chirouze C, Obadia J-F, Duval X, Hoen B, Group AS. 2016. Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. European Heart Journal 37:840–848.
1.
Iung B, Rahimtoola SH, Vahanian A. 2016. The year in cardiology 2015: valvular heart disease. European Heart Journal 37:442–448.
1.
Iung B, Vahanian A. 2016. Valve weight in aortic stenosis: back to the basics. European Heart Journal 37:700–702.
1.
Jilaihawi H, Chen M, Webb J, Himbert D, Ruiz CE, Rodés-Cabau J, Pache G, Colombo A, Nickenig G, Lee M, Tamburino C, Sievert H, Abramowitz Y, Tarantini G, Alqoofi F, Chakravarty T, Kashif M, Takahashi N, Kazuno Y, Maeno Y, Kawamori H, Chieffo A, Blanke P, Dvir D, Ribeiro HB, Feng Y, Zhao Z-G, Sinning J-M, Kliger C, Giustino G, Pajerski B, Imme S, Grube E, Leipsic J, Vahanian A, Michev I, Jelnin V, Latib A, Cheng W, Makkar R. 2016. A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. JACC: Cardiovascular imaging 9:1145–1158.
1.
Juliard J-M, Golmard J-L, Feldman LJ, Himbert D, Nejjari M, Ducrocq G, Sorbets E, Garbarz E, Aubry P, Duchatelle V, Vahanian A, Steg PG. 2016. Impact of participation in randomized trials of reperfusion therapy on the time to reperfusion and hospital mortality in ST-segment elevation myocardial infarction: A single-centre cohort study. Eur Heart J Acute Cardiovasc Care 5:193–197.
1.
Le Goff C, Rogers C, Le Goff W, Pinto G, Bonnet D, Chrabieh M, Alibeu O, Nistchke P, Munnich A, Picard C, Cormier-Daire V. 2016. Heterozygous Mutations in MAP3K7, Encoding TGF-β-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome. American Journal of Human Genetics 99:407–413.
1.
Lenuzza N, Duval X, Nicolas G, Thévenot E, Job S, Videau O, Narjoz C, Loriot M-A, Beaune P, Becquemont L, Mentré F, Funck-Brentano C, Alavoine L, Arnaud P, Delaforge M, Bénech H. 2016. Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers. European Journal of Drug Metabolism and Pharmacokinetics 41:125–138.
1.
Lindman BR, Clavel M-A, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P. 2016. Calcific aortic stenosis. Nat Rev Dis Primers 2:16006.
1.
Liu G, Ma H, Xie H, Xuan N, Guo X, Fan Z, Rajashekar B, Arnaud P, Offmann B, Picimbon J-F. 2016. Biotype Characterization, Developmental Profiling, Insecticide Response and Binding Property of Bemisia tabaci Chemosensory Proteins: Role of CSP in Insect Defense. PloS One 11:e0154706.
1.
Lopes M, Abrahim B, Veiga F, Seiça R, Cabral LM, Arnaud P, Andrade JC, Ribeiro AJ. 2016. Preparation methods and applications behind alginate-based particles. Expert Opin Drug Deliv 1–14.
1.
Maisano F, Taramasso M, Nickenig G, Hammerstingl C, Vahanian A, Messika-Zeitoun D, Baldus S, Huntgeburth M, Alfieri O, Colombo A, La Canna G, Agricola E, Zuber M, Tanner FC, Topilsky Y, Kreidel F, Kuck K-H. 2016. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. European Heart Journal 37:817–825.
1.
Maupetit-Méhouas S, Montibus B, Nury D, Tayama C, Wassef M, Kota SK, Fogli A, Cerqueira Campos F, Hata K, Feil R, Margueron R, Nakabayashi K, Court F, Arnaud P. 2016. Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactive. Nucleic Acids Research 44:621–635.
1.
McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, Himbert D, Asnes JD, Salizzoni S, Bocks ML, Cheatham JP, Momenah TS, Kim DW, Schranz D, Meadows J, Thomson JDR, Goldstein BH, Crittendon I, Fagan TE, Webb JG, Horlick E, Delaney JW, Jones TK, Shahanavaz S, Moretti C, Hainstock MR, Kenny DP, Berger F, Rihal CS, Dvir D, Valve-in-Valve International Database R. 2016. Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study. Circulation 133:1582–1593.
1.
McInerney-Leo AM, Le Goff C, Leo PJ, Kenna TJ, Keith P, Harris JE, Steer R, Bole-Feysot C, Nitschke P, Kielty C, Brown MA, Zankl A, Duncan EL, Cormier-Daire V. 2016. Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia. Journal of Medical Genetics 53:457–464.
1.
Milleron O, Bouleti C, Mazouz S, Brochet E, Rouzet F, Nataf P, Ghodbane W, Messika-Zeitoun D, Dilly MP, Cattan S, Vahanian A, Iung B, Jondeau G. 2016. Eclipsed mitral regurgitation: an unusual cause of acute heart failure. European Heart Journal Cardiovascular Imaging.
1.
Naoufel Z, Hebi M, Ajebli M, Michel JB, Eddouks M. 2016. In vitro vasorelaxant effect of Artemisia herba alba Asso. in spontaneously hypertensive rats. Cardiovascular & Hematological Agents in Medicinal Chemistry.
1.
Nchimi A, Courtois A, El Hachemi M, Touat Z, Drion P, Withofs N, Warnock G, Bahri M-A, Dogné J-M, Cheramy-Bien J-P, Schoysman L, Joskin J, Michel J-B, Defraigne J-O, Plenevaux A, Sakalihasan N. 2016. Multimodality imaging assessment of the deleterious role of the intraluminal thrombus on the growth of abdominal aortic aneurysm in a rat model. European Radiology 26:2378–2386.
1.
Nejjari M, Himbert D, Brochet E, Attias D. 2016. First-in-man full percutaneous transfemoral valve-in-valve implantations using Edwards SAPIEN 3 prostheses to treat a patient with degenerated mitral and aortic bioprostheses. Interactive Cardiovascular and Thoracic Surgery 23:508–510.
1.
Nguyen V, Mathieu T, Melissopoulou M, Cimadevilla C, Codogno I, Huart V, Duval X, Vahanian A, Messika-Zeitoun D. 2016. Sex Differences in the Progression of Aortic Stenosis and Prognostic Implication: The COFRASA-GENERAC Study. JACC Cardiovascular imaging 9:499–501.
1.
Nguyen A, Urena M, Himbert D, Goublaire C, Brochet E, Gardy-Verdonk C, Carrasco JL, Ghodbane W, Nataf P, Vahanian A. 2016. Late Displacement After Transcatheter Mitral Valve Replacement for Degenerative Mitral Valve Disease With Massive Annular Calcification. JACC Cardiovascular interventions 9:1633–1634.
1.
Nickenig G, Hammerstingl C, Schueler R, Topilsky Y, Grayburn PA, Vahanian A, Messika-Zeitoun D, Urena Alcazar M, Baldus S, Volker R, Huntgeburth M, Alfieri O, Latib A, La Canna G, Agricola E, Colombo A, Kuck K-H, Kreidel F, Frerker C, Tanner FC, Ben-Yehuda O, Maisano F. 2016. Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System. JACC Cardiovascular interventions 9:2039–2047.
1.
Nishimura RA, Vahanian A, Eleid MF, Mack MJ. 2016. Mitral valve disease–current management and future challenges. Lancet 387:1324–1334.
1.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force M. 2016. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal 37:2129–2200.
1.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force M, Document R. 2016. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure 18:891–975.
1.
Puri R, Iung B, Cohen DJ, Rodés-Cabau J. 2016. TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. European Heart Journal 37:2217–2225.
1.
Regueiro A, Linke A, Latib A, Ihlemann N, Urena M, Walther T, Husser O, Herrmann HC, Nombela-Franco L, Cheema AN, Le Breton H, Stortecky S, Kapadia S, Bartorelli AL, Sinning JM, Amat-Santos I, Munoz-Garcia A, Lerakis S, Gutiérrez-Ibanes E, Abdel-Wahab M, Tchetche D, Testa L, Eltchaninoff H, Livi U, Castillo JC, Jilaihawi H, Webb JG, Barbanti M, Kodali S, de Brito FS, Ribeiro HB, Miceli A, Fiorina C, Dato GMA, Rosato F, Serra V, Masson J-B, Wijeysundera HC, Mangione JA, Ferreira M-C, Lima VC, Carvalho LA, Abizaid A, Marino MA, Esteves V, Andrea JCM, Giannini F, Messika-Zeitoun D, Himbert D, Kim W-K, Pellegrini C, Auffret V, Nietlispach F, Pilgrim T, Durand E, Lisko J, Makkar RR, Lemos PA, Leon MB, Puri R, San Roman A, Vahanian A, Søndergaard L, Mangner N, Rodés-Cabau J. 2016. Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death. JAMA 316:1083–1092.
1.
Rodés-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, Schofer J, Campelo-Parada F, Puri R, Vahanian A. 2016. Transcatheter Therapies for Treating Tricuspid Regurgitation. Journal of the American College of Cardiology 67:1829–1845.
1.
Salaun E, Pankert M, Habib G, Bonnet J-L, Vahanian A, Himbert D, Brochet E, Nataf P, D’Ancona G, Kische S, Öner A, Ince H. 2016. How should I treat refractory cardiogenic shock in a patient with chronic biventricular heart failure and mitral regurgitation with difficult valve characteristics? EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 11:1201–1206.
1.
Sawaya F, Kappetein AP, Wisser W, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T. 2016. Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 12:775–782.
1.
Simonato M, Azadani AN, Webb J, Leipsic J, Kornowski R, Vahanian A, Wood D, Piazza N, Kodali S, Ye J, Whisenant B, Gaia D, Aziz M, Pasala T, Mehilli J, Wijeysundera HC, Tchetche D, Moat N, Teles R, Petronio AS, Hildick-Smith D, Landes U, Windecker S, Arbel Y, Mendiz O, Makkar R, Tseng E, Dvir D. 2016. In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 12:909–917.
1.
Simonato M, Webb J, Kornowski R, Vahanian A, Frerker C, Nissen H, Bleiziffer S, Duncan A, Rodés-Cabau J, Attizzani GF, Horlick E, Latib A, Bekeredjian R, Barbanti M, Lefevre T, Cerillo A, Hernández JM, Bruschi G, Spargias K, Iadanza A, Brecker S, Palma JH, Finkelstein A, Abdel-Wahab M, Lemos P, Petronio AS, Champagnac D, Sinning J-M, Salizzoni S, Napodano M, Fiorina C, Marzocchi A, Leon M, Dvir D. 2016. Transcatheter Replacement of Failed Bioprosthetic Valves: Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics After Aortic Valve-in-Valve. Circulation: Cardiovascular Interventions 9.
1.
Slicker K, Lane WG, Oyetayo OO, Copeland LA, Stock EM, Michel JB, Erwin JP. 2016. Daily cardiac catheterization procedural volume and complications at an academic medical center. Cardiovasc Diagn Therap 6:446–452.
1.
Stehlik J, Bavaria JE, Bax J, Cronenwett JL, Edwards LB, Fairman RM, Ferrari R, Jacobs JP, Johnson MR, Kraiss LW, Masoudi FA, Mehra MR, Vahanian A, Walsh MN, Lund LH. 2016. Heart, lung, and vascular registries: Evolving goals, successful approaches, and ongoing innovation. Journal of Heart and Lung Transplantation 35:1149–1157.
1.
Tarantini G, Mojoli M, Urena M, Vahanian A. 2016. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. European Heart Journal.
1.
Tarantini G, Mojoli M, Windecker S, Wendler O, Lefèvre T, Saia F, Walther T, Rubino P, Bartorelli AL, Napodano M, D’Onofrio A, Gerosa G, Iliceto S, Vahanian A. 2016. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry. JACC Cardiovascular interventions 9:937–946.
1.
Tribouilloy C, Bohbot Y, Maréchaux S, Debry N, Delpierre Q, Peltier M, Diouf M, Slama M, Messika-Zeitoun D, Rusinaru D. 2016. Outcome Implication of Aortic Valve Area Normalized to Body Size in Asymptomatic Aortic Stenosis. Circulation: Cardiovascular Imaging 9.
1.
Tubiana S, Duval X, Alla F, Selton-Suty C, Tattevin P, Delahaye F, Piroth L, Chirouze C, Lavigne J-P, Erpelding M-L, Hoen B, Vandenesch F, Iung B, Le Moing V, Group VAS. 2016. The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. Journal of Infection 72:544–553.
1.
Urena M, Himbert D, Ohlmann P, Capretti G, Goublaire C, Kindo M, Morel O, Ghodbane W, Iung B, Vahanian A. 2016. Transcatheter Aortic Valve Replacement to Treat Pure Aortic Regurgitation on Noncalcified Native Valves. Journal of the American College of Cardiology 68:1705–1706.
1.
Vahanian A. 2016. CardioPulse: Valvular interventions from the Europeanperspective. European Heart Journal 37:796–797.
1.
Vahanian A, Himbert D. 2016. Transcatheter Aortic Valve Replacement: The Good Results of the New Generation of Transcatheter Aortic Valve Replacement Devices Are Confirmed. JACC Cardiovascular interventions 9:385–386.
1.
Vahanian A, Iung B. 2016. Mitral regurgitation. Timing of surgery or interventional treatment. Herz 41:3–9.
1.
Vahanian A, Nataf P. 2016. Let us preserve the harmonious development of transcatheter aortic valve implantation! European Heart Journal 37:2249–2251.
1.
Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence MS, Redwood S, Kahlert P, Rodes-Cabau J, Leipsic J, Webb J. 2016. Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 12:e235–243.
1.
Zarka S, Bouleti C, Arangalage D, Chopra H, Chillon S, Henry-Feugeas M-C, Abtan J, Juliard J-M, Iung B, Vahanian A, Laissy J-P, Ou P. 2016. Usefulness of Subepicardial Hyperemia on Contrast-Enhanced First-Pass Magnetic Resonance Perfusion Imaging for Diagnosis of Acute Myocarditis. American Journal of Cardiology 118:440–445.
1.
Zayani Y, Allal-Elasmi M, Zidi W, Guizani I, Jacob MP, Feki M, Kaabachi N. 2016. Abnormal Circulating Levels of Metalloproteinase and Their Inhibitor in Hypertensive Patients. Clinical Laboratory 62:527–533.

2015

1.
Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, Lerakis S, Cheema AN, Gutiérrez-Ibanes E, Munoz A, Pan M, Webb JG, Herrmann H, Kodali S, Nombela-Franco L, Tamburino C, Jilaihawi H, Masson J-B, Sandoli de Brito F, Cristina Ferreira M, Lima VC, Mangione JA, Iung B, Vahanian A, Durand E, Tuzcu M, Hayek SS, Angulo-Llanos R, Gómez-Doblas JJ, Castillo JC, Dvir D, Leon MB, Garcia E, Cobiella J, Barbanti M, Makkar R, Barbosa Ribeiro H, Urena M, Dumont E, Pibarot P, Lopez J, San Roman A, Rodés-Cabau J. 2015. Response to Letters Regarding Article, “Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry.” Circulation 132:e372–374.
1.
Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, Lerakis S, Cheema AN, Gutiérrez-Ibanes E, Munoz-Garcia AJ, Pan M, Webb JG, Herrmann HC, Kodali S, Nombela-Franco L, Tamburino C, Jilaihawi H, Masson J-B, de Brito FS, Ferreira MC, Lima VC, Mangione JA, Iung B, Vahanian A, Durand E, Tuzcu EM, Hayek SS, Angulo-Llanos R, Gómez-Doblas JJ, Castillo JC, Dvir D, Leon MB, Garcia E, Cobiella J, Vilacosta I, Barbanti M, R Makkar R, Ribeiro HB, Urena M, Dumont E, Pibarot P, Lopez J, San Roman A, Rodés-Cabau J. 2015. Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation 131:1566–1574.
1.
Arai T, Morice M-C, O’Connor SA, Yamamoto M, Eltchaninoff H, Leguerrier A, Leprince P, Laskar M, Iung B, Fajadet J, Prat A, Lièvre M, Donzeau-Gouge P, Chevreul K, Teiger E, Lefèvre T, Gilard M, Investigators FR. 2015. Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry). Catheterization and Cardiovascular Interventions 85:1231–1239.
1.
Barbash IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, Abramowitz Y, Latib A, Nguyen C, Deuschl F, Segev A, Sideris K, Buccheri S, Simonato M, Rosa FD, Tamburino C, Jilaihawi H, Miyazaki T, Himbert D, Schofer N, Guetta V, Bleiziffer S, Tchetche D, Immè S, Makkar RR, Vahanian A, Treede H, Lange R, Colombo A, Dvir D. 2015. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. European Heart Journal 36:3370–3379.
1.
Baudry G, Bouleti C, Iung B, Nejjari M, Laissy JP, Vahanian A, Ou P. 2015. Diagnosis of acute myocarditis with dual source cardiac tomography. International Journal of Cardiology 179:256–257.
1.
Berti S, Cerillo AG, Murzi M, Mariani M, Marchi F, Schäfer U, Attia R, Bapat V, Himbert D, Brochet E, Depoix JP, Nataf P, Vahanian A. 2015. How should I treat a severely symptomatic, high-risk female patient with degenerated mitral (Carpentier-Edwards porcine) and aortic (Sorin Mitroflow) bioprostheses? EuroIntervention 10:1250–1252.
1.
Bière L, Launay M, Pinaud F, Hamel J-F, Eltchaninoff H, Iung B, Laskar M, Leguerrier A, Gilard M, Furber A. 2015. Influence of sex on mortality and perioperative outcomes in patients undergoing TAVR: insights from the FRANCE 2 registry. Journal of the American College of Cardiology 65:755–757.
1.
Bouchiat C, Moreau K, Devillard S, Rasigade J-P, Mosnier A, Geissmann T, Bes M, Tristan A, Lina G, Laurent F, Piroth L, Aissa N, Duval X, Le Moing V, Vandenesch F, French VSG. 2015. Staphylococcus aureus infective endocarditis versus bacteremia strains: Subtle genetic differences at stake. Infection, Genetics and Evolution 36:524–530.
1.
Bouleti C, Fassa A-A, Himbert D, Brochet E, Ducrocq G, Nejjari M, Ghodbane W, Depoix J-P, Nataf P, Vahanian A. 2015. Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty. JACC: Cardiovascular interventions 8:83–91.
1.
Bouleti C, Himbert D, Brochet E, Ou P, Iung B, Nejjari M, Ghodbane W, Fassa A-A, Depoix J-P, Vahanian A. 2015. Transfemoral tricuspid valve-in-ring implantation using the edwards Sapien XT valve: one-year follow-up. Circulation: Cardiovascular Interventions 8.
1.
Bouleti C, Himbert D, Iung B, Alos B, Kerneis C, Ghodbane W, Messika-Zeitoun D, Brochet E, Fassa A-A, Depoix J-P, Ou P, Nataf P, Vahanian A. 2015. Long-term outcome after transcatheter aortic valve implantation. Heart (British Cardiac Society) 101:936–942.
1.
Bouleti C, Mathivet T, Serfaty J-M, Vignolles N, Berland E, Monnot C, Cluzel P, Steg PG, Montalescot G, Germain S. 2015. Angiopoietin-like 4 serum levels on admission for acute myocardial infarction are associated with no-reflow. International Journal of Cardiology 187:511–516.
1.
Bouleti C, Mewton N, Germain S. 2015. The no-reflow phenomenon: State of the art. Archives of Cardiovascular Diseases 108:661–674.
1.
Burillo E, Lindholt JS, Molina-Sánchez P, Jorge I, Martinez-Pinna R, Blanco-Colio LM, Tarin C, Torres-Fonseca MM, Esteban M, Laustsen J, Ramos-Mozo P, Calvo E, Lopez JA, Vega de Ceniga M, Michel J-B, Egido J, Andrés V, Vazquéz J, Meilhac O, Martin-Ventura JL. 2015. ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression. Thrombosis and Haemostasis 113:1335–1346.
1.
Castellant P, Didier R, Bezon E, Couturaud F, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Laskar M, Boschat J, Gilard M, Investigators F. 2015. Comparison of Outcome of Transcatheter Aortic Valve Implantation With Versus Without Previous Coronary Artery Bypass Grafting (from the FRANCE 2 Registry). American Journal of Cardiology 116:420–425.
1.
Causse X, Cadranel J-F, Potier P, Hanslik B, Denis J, Renou C, Delasalle P, Club de Réflexion des Cabinets et Groupes d’Hépato-G, Association Nationale des hépato-Gastroentérologues des Hôpitaux généraux de F. 2015. Hepatogastroenterologists’ knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey. European Journal of Gastroenterology and Hepatology 27:544–549.
1.
Chandra A, Patel D, Aragon-Martin JA, Pinard A, Collod-Béroud G, Comeglio P, Boileau C, Faivre L, Charteris D, Child AH, Arno G. 2015. The revised ghent nosology; reclassifying isolated ectopia lentis. Clinical Genetics 87:284–287.
1.
Chopard R, Teiger E, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Mouillet G, Schiele F, Investigators F-. 2015. Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry. JACC Cardiovascular interventions 8:1346–1355.
1.
Cimadevilla C, Nadia B, Dreyfus J, Perez F, Cueff C, Malanca M, Brochet E, Iung B, Vahanian A, Messika-Zeitoun D. 2015. Echocardiographic measurement of left atrial volume: Does the method matter? Archives of Cardiovascular Diseases 108:643–649.
1.
Clavel M-A, Malouf J, Messika-Zeitoun D, Araoz PA, Michelena HI, Enriquez-Sarano M. 2015. Aortic valve area calculation in aortic stenosis by CT and Doppler echocardiography. JACC: Cardiovascular imaging 8:248–257.
1.
Clavel M-A, Malouf J, Messika-Zeitoun D, Araoz PA, Michelena HI, Enriquez-Sarano M. 2015. Reply: Comparison of Echocardiography and CT for the Assessment of Aortic Stenosis Valve Area. JACC: Cardiovascular imaging 8:1116.
1.
Clement M, Guedj K, Andreata F, Morvan M, Bey L, Khallou-Laschet J, Gaston A-T, Delbosc S, Alsac J-M, Bruneval P, Deschildre C, Le Borgne M, Castier Y, Kim H-J, Cantor H, Michel J-B, Caligiuri G, Nicoletti A. 2015. Control of the T follicular helper-germinal center B-cell axis by CD8+ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation 131:560–570.
1.
Clerfond G, Pereira B, Innorta A, Motreff P, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Teiger E, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Souteyrand G. 2015. Comparison of outcomes after one-versus-two transcatheter aortic valve implantation during a same procedure (from the FRANCE2 Registry). American Journal of Cardiology 115:1273–1280.
1.
Dallaudiere B, Louedec L, Lenet MPJ, Pesquer L, Blaise E, Perozziello A, Michel JB, Moinard M, Meyer P, Serfaty JM. 2015. The molecular systemic and local effects of intra-tendinous injection of Platelet Rich Plasma in tendinosis: preliminary results on a rat model with ELISA method. Muscles Ligaments Tendons J 5:99–105.
1.
Desilles J-P, Loyau S, Syvannarath V, Gonzalez-Valcarcel J, Cantier M, Louedec L, Lapergue B, Amarenco P, Ajzenberg N, Jandrot-Perrus M, Michel J-B, Ho-Tin-Noe B, Mazighi M. 2015. Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke. Stroke 46:3241–3248.
1.
Dreyfus J, Durand-Viel G, Raffoul R, Alkhoder S, Hvass U, Radu C, Al-Attar N, Ghodbhane W, Attias D, Nataf P, Vahanian A, Messika-Zeitoun D. 2015. Comparison of 2-Dimensional, 3-Dimensional, and Surgical Measurements of the Tricuspid Annulus Size: Clinical Implications. Circulation: Cardiovascular Imaging 8:e003241.
1.
Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwoger M, Haverich A, Iung B, John Manolis A, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, von Allmen RS, Vrints CJM, Authors/Task Force members. 2015. Corrigendum to: 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. European Heart Journal 36:2779.
1.
Furuta A, Lellouche N, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Dubois-Rande J-L, Teiger E. 2015. Impact of previous acute pulmonary oedema after transcatheter aortic valve implantation: insight from French Aortic National CoreValve and Edwards 2 [FRANCE 2]registry. International Journal of Cardiology 183:98–104.
1.
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Document R, Erol Ç, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GYH, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM. 2015. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal 36:3075–3128.
1.
Himbert D, Vahanian A. 2015. Transcatheter aortic valve replacement for patients with heart failure. Heart Failure Clinics 11:231–242.
1.
Iung B. 2015. Antithrombotic therapy after transcatheter aortic valve implantation. Heart (British Cardiac Society) 101:1089–1090.
1.
Iung B. 2015. New ESC guidelines: aortic disease. Heart (British Cardiac Society) 101:421–423.
1.
Iung B, Laouenan C, Vahanian A, Gilard M. 2015. Considerations on the poor discriminatory power of the FRANCE-2 risk score: Authors’ reply. Heart (British Cardiac Society) 101:1170.
1.
Iung B, Tubiana S, Alla F, Lavielle M. 2015. Infective endocarditis and antibiotic prophylaxis. Lancet 386:529–530.
1.
Latib A, Agricola E, Pozzoli A, Denti P, Taramasso M, Spagnolo P, Juliard J-M, Brochet E, Ou P, Enriquez-Sarano M, Grigioni F, Alfieri O, Vahanian A, Colombo A, Maisano F. 2015. First-in-Man Implantation of a Tricuspid Annular Remodeling Device for Functional Tricuspid Regurgitation. JACC Cardiovascular interventions 8:e211–214.
1.
Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, Baumgartner H, Finkelstein A, Legrand V, de Lezo JS, Kefer J, Messika-Zeitoun D, Richardt G, Stabile E, Kaleschke G, Vahanian A, Laborde J-C, Leon MB, Webb JG, Panoulas VF, Maisano F, Alfieri O, Colombo A. 2015. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circulation: Cardiovascular Interventions 8.
1.
Le Goff C, Cormier-Daire V. 2015. Chondrodysplasias and TGFβ signaling. BoneKEy Reports 4:642.
1.
Le Moing V, Alla F, Doco-Lecompte T, Delahaye F, Piroth L, Chirouze C, Tattevin P, Lavigne J-P, Erpelding M-L, Hoen B, Vandenesch F, Duval X, group V study. 2015. Staphylococcus aureus Bloodstream Infection and Endocarditis–A Prospective Cohort Study. PloS One 10:e0127385.
1.
Lefébure A, Papy E, Rioux C, Diamantis S, Armand-Lefèvre L, Longuet P, Lescure FX, Wolff M, Arnaud P, Lucet JC. 2015. Audit of carbapenem prescriptions comparing 2 assessment periods. Med Mal Infect 45:273–278.
1.
Maisano F, Alfieri O, Banai S, Buchbinder M, Colombo A, Falk V, Feldman T, Franzen O, Herrmann H, Kar S, Kuck K-H, Lutter G, Mack M, Nickenig G, Piazza N, Reisman M, Ruiz CE, Schofer J, Søndergaard L, Stone GW, Taramasso M, Thomas M, Vahanian A, Webb J, Windecker S, Leon MB. 2015. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? European Heart Journal 36:1651–1659.
1.
Maubec E, Laouénan C, Deschamps L, Nguyen VT, Scheer-Senyarich I, Wackenheim-Jacobs A-C, Steff M, Duhamel S, Tubiana S, Brahimi N, Leclerc-Mercier S, Crickx B, Perret C, Aractingi S, Escoubet B, Duval X, Arnaud P, Jaisser F, Mentré F, Farman N. 2015. Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin. Journal of Investigative Dermatology 135:1781–1789.
1.
Meurin P, Brandao Carreira V, Dumaine R, Shqueir A, Milleron O, Safar B, Perna S, Smadja C, Genest M, Garot J, Carette B, Payot L, Tabet JY, College National des Cardiologues F, Collège National des Cardiologues des Hôpitaux Français PF. 2015. Incidence, diagnostic methods, and evolution of left ventricular thrombus in patients with anterior myocardial infarction and low left ventricular ejection fraction: a prospective multicenter study. American Heart Journal 170:256–262.
1.
Michel J-B, Ho-Tin-Noé B. 2015. Thrombi and neutrophils. Circulation Research 116:1107–1108.
1.
Mirabel M, André R, Barsoum Mikhaïl P, Colboc H, Lacassin F, Noël B, Robert J, Nadra M, Braunstein C, Gervolino S, Marijon E, Iung B, Jouven X. 2015. Infective endocarditis in the Pacific: clinical characteristics, treatment and long-term outcomes. Open Heart 2:e000183.
1.
Mirabel M, André R, Barsoum P, Colboc H, Lacassin F, Noel B, Axler O, Phelippeau G, Braunstein C, Marijon E, Iung B, Jouven X. 2015. Ethnic disparities in the incidence of infective endocarditis in the Pacific. International Journal of Cardiology 186:43–44.
1.
Nguyen C, Cheong AP, Himbert D. 2015. Valve-in-valve-in-valve: Treating endocarditis of a transcatheter heart valve. Catheterization and Cardiovascular Interventions 86:E200–204.
1.
Nguyen V, Cimadevilla C, Estellat C, Codogno I, Huart V, Benessiano J, Duval X, Pibarot P, Clavel MA, Enriquez-Sarano M, Vahanian A, Messika-Zeitoun D. 2015. Haemodynamic and anatomic progression of aortic stenosis. Heart (British Cardiac Society) 101:943–947.
1.
Obadia J-F, Armoiry X, Iung B, Lefèvre T, Mewton N, Messika-Zeitoun D, Cormier B, Berthiller J, Maucort-Boulch D, Boutitie F, Vaz B, Trochu J-N, Vahanian A. 2015. The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 10:1354–1360.
1.
Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande J-L, Teiger E, investigators FR. 2015. Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 10:e1–9.
1.
Piepoli MF, Binno S, Corrà U, Seferovic P, Conraads V, Jaarsma T, Schmid J-P, Filippatos G, Ponikowski PP, Committee on Exercise P, Training of the Heart Failure Association of the ESC. 2015. ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients. European Journal of Heart Failure 17:631–638.
1.
Pierard LA, Vahanian A. 2015. The year in cardiology 2014: valvular heart disease. European Heart Journal 36:416–420.
1.
Plurien F, Bruneval P, Jobic Y, Iung B, Ennezat P-V. 2015. Calcifications in benfluorex-induced valve heart disease: a misknown association. Cardiology 130:87–90.
1.
Raal FJ, Honarpour N, Blom DJ, Hovingh GK, Xu F, Scott R, Wasserman SM, Stein EA, Investigators T. 2015. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial. Lancet 385:341–350.
1.
Rubio-Navarro A, Amaro Villalobos JM, Lindholt JS, Buendía I, Egido J, Blanco-Colio LM, Samaniego R, Meilhac O, Michel JB, Martín-Ventura JL, Moreno JA. 2015. Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm. International Journal of Cardiology 201:66–78.
1.
Ruys TPE, Roos-Hesselink JW, Pijuan-Domènech A, Vasario E, Gaisin IR, Iung B, Freeman LJ, Gordon EP, Pieper PG, Hall R, Boersma E, Johnson MR, investigators R. 2015. Is a planned caesarean section in women with cardiac disease beneficial? Heart (British Cardiac Society) 101:530–536.
1.
Sakalihasan N, Nienaber CA, Hustinx R, Lovinfosse P, El Hachemi M, Cheramy-Bien J-P, Seidel L, Lavigne J-P, Quaniers J, Kerstenne M-A, Courtois A, Ooms A, Albert A, Defraigne J-O, Michel J-B. 2015. (Tissue PET) Vascular metabolic imaging and peripheral plasma biomarkers in the evolution of chronic aortic dissections. European Heart Journal Cardiovascular Imaging 16:626–633.
1.
Schymik G, Lefèvre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A. 2015. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. JACC Cardiovascular interventions 8:657–669.
1.
Stone GW, Adams DH, Abraham WT, Kappetein AP, Généreux P, Vranckx P, Mehran R, Kuck K-H, Leon MB, Piazza N, Head SJ, Filippatos G, Vahanian AS, Mitral Valve Academic Research C. 2015. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. Journal of the American College of Cardiology 66:308–321.
1.
Stone GW, Adams DH, Abraham WT, Kappetein AP, Généreux P, Vranckx P, Mehran R, Kuck K-H, Leon MB, Piazza N, Head SJ, Filippatos G, Vahanian AS, Mitral Valve Academic Research C. 2015. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium. European Heart Journal 36:1878–1891.
1.
Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP, Mitral Valve Academic Research C. 2015. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium. Journal of the American College of Cardiology 66:278–307.
1.
Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP, Mitral Valve Academic Research C. 2015. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium. European Heart Journal 36:1851–1877.
1.
Suzuki M, Bachelet-Violette L, Rouzet F, Beilvert A, Autret G, Maire M, Menager C, Louedec L, Choqueux C, Saboural P, Haddad O, Chauvierre C, Chaubet F, Michel J-B, Serfaty J-M, Letourneur D. 2015. Ultrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombus. Nanomedicine 10:73–87.
1.
Urena M, Himbert D, Rodés-Cabau J, Vahanian A. 2015. Percutaneous aortic valve interventions in heart failure patients. Minerva Cardioangiologica 63:547–561.
1.
Urena M, Webb JG, Eltchaninoff H, Muñoz-García AJ, Bouleti C, Tamburino C, Nombela-Franco L, Nietlispach F, Moris C, Ruel M, Dager AE, Serra V, Cheema AN, Amat-Santos IJ, de Brito FS, Lemos PA, Abizaid A, Sarmento-Leite R, Ribeiro HB, Dumont E, Barbanti M, Durand E, Alonso Briales JH, Himbert D, Vahanian A, Immè S, Garcia E, Maisano F, del Valle R, Benitez LM, García del Blanco B, Gutiérrez H, Perin MA, Siqueira D, Bernardi G, Philippon F, Rodés-Cabau J. 2015. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. Journal of the American College of Cardiology 65:437–448.
1.
Vahanian A. 2015. New perspectives: transcatheter aortic valve implantation in the year 2020. European Heart Journal 36:1200.
1.
Vahanian A, Himbert D, Brochet E. 2015. Multiple valve disease - assessment, strategy and intervention. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 11 Suppl W:W14–16.
1.
Vahanian A, Iung B. 2015. Severe secondary mitral regurgitation and left ventricular dysfunction: a “deadly combination” against which the fight is not over! European Heart Journal 36:2742–2744.
1.
Vahanian A, Juliard JM. 2015. When Transcatheter Therapy Moves to the “Forgotten Valve.” Journal of the American College of Cardiology 66:2484–2486.
1.
Valeanu L, Depoix J-P, Enguerand D, Tini L, Dilly M-P, Raffoul R, Bourgeois-Moine A, Rajguru M, Longrois D, Iung B, Montravers P. 2015. Pregnancy in a Patient With Severe Aortic Stenosis Requiring Unusual Management. Journal of Cardiothoracic and Vascular Anesthesia 29:1632–1635.
1.
Van Belle E, Juthier F, Susen S, Vincentelli A, Dallongeville J, Iung B, Eltchaninoff H, Laskar M, Leprince P, Lievre M, Banfi C, Auffray J-L, Delhaye C, Donzeau-Gouge P, Chevreul K, Fajadet J, Leguerrier A, Prat A, Gilard M, Teiger E, Investigators F. 2015. Response to letter regarding article, “postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 registry.” Circulation 131:e16–17.
1.
Van Gils L, Baumbach A, Himbert D, Lansky AJ, Vahanian A, Van Mieghem NM. 2015. Tools and Techniques - Clinical: Embolic protection devices in transcatheter aortic valve implantation. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 11:247–248.
1.
Veselovska L, Smallwood SA, Saadeh H, Stewart KR, Krueger F, Maupetit-Méhouas S, Arnaud P, Tomizawa S-I, Andrews S, Kelsey G. 2015. Erratum to: Deep sequencing and de novo assembly of the mouse occyte transcriptome define the contribution of transcription to the DNA methylation landscape. Genome Biology 16:271.
1.
Veselovska L, Smallwood SA, Saadeh H, Stewart KR, Krueger F, Maupetit-Méhouas S, Arnaud P, Tomizawa S-I, Andrews S, Kelsey G. 2015. Deep sequencing and de novo assembly of the mouse oocyte transcriptome define the contribution of transcription to the DNA methylation landscape. Genome Biology 16:209.
1.
Yang T-H, Webb JG, Blanke P, Dvir D, Hansson NC, Nørgaard BL, Thompson CR, Thomas M, Wendler O, Vahanian A, Himbert D, Kodali SK, Hahn RT, Thourani VH, Schymik G, Precious B, Berger A, Wood DA, Pibarot P, Rodés-Cabau J, Jaber WA, Leon MB, Walther T, Leipsic J. 2015. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. JACC Cardiovascular interventions 8:462–471.

2014

1.
Alexoiu VL, Ou P, Messika-Zeitoun D, Jacob BL, Kirsch M. 2014. Post-Traumatic Aortic Arch Aneurysm Complicated by Aorto-Pulmonary Fistula. Aorta 2:293–295.
1.
Amabile N, Agostini H, Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Laskar M, Caussin C. 2014. Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry. EuroIntervention 10:842–849.
1.
Amsallem M, Iung B, Bouleti C, Armand-Lefevre L, Eme A-L, Touati A, Kirsch M, Duval X, Vahanian A. 2014. First reported human case of native mitral infective endocarditis caused by Streptococcus canis. Canadian Journal of Cardiology 30:1462.e1–2.
1.
Arangalage D, Cimadevilla C, Alkhoder S, Chiampan A, Himbert D, Brochet E, Iung B, Nataf P, Depoix J-P, Vahanian A, Messika-Zeitoun D. 2014. Agreement between the new EuroSCORE II, the Logistic EuroSCORE and the Society of Thoracic Surgeons score: implications for transcatheter aortic valve implantation. Archives of Cardiovascular Diseases 107:353–360.
1.
Arsenault BJ, Dubé M-P, Brodeur MR, de Oliveira Moraes AB, Lavoie V, Kernaleguen A-E, Guauque-Olarte S, Mathieu P, Pibarot P, Messika-Zeitoun D, Bossé Y, Rhainds D, Rhéaume E, Tardif J-C. 2014. Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans. Arteriosclerosis, Thrombosis, and Vascular Biology 34:457–462.
1.
Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, Hamm C, Kappetein AP, Leipsic J, Leon MB, MacCarthy P, Piazza N, Pibarot P, Roberts WC, Rodés-Cabau J, Serruys PW, Thomas M, Vahanian A, Webb J, Zamorano JL, Windecker S. 2014. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. European Heart Journal 35:2639–2654.
1.
Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, Hamm C, Kappetein AP, Leipsic J, Leon MB, MacCarthy P, Piazza N, Pibarot P, Roberts WC, Rodés-Cabau J, Serruys PW, Thomas M, Vahanian A, Webb J, Zamorano JL, Windecker S. 2014. Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. European Heart Journal 35:2627–2638.
1.
Benali K, Louedec L, Azzouna RB, Merceron O, Nassar P, Al Shoukr F, Petiet A, Barbato D, Michel J-B, Sarda-Mantel L, Le Guludec D, Rouzet F. 2014. Preclinical validation of 99mTc-annexin A5-128 in experimental autoimmune myocarditis and infective endocarditis: comparison with 99mTc-HYNIC-annexin A5. Molecular Imaging 13.
1.
Bouallouche SA, Bouziane A, Laali M, Safar B, Milleron O. 2014. Giant left atrial appendage aneurysm. European Heart Journal Cardiovascular Imaging 15:862.
1.
Bouleti C, Iung B, Himbert D, Messika-Zeitoun D, Brochet E, Garbarz E, Cormier B, Vahanian A. 2014. Relationship between valve calcification and long-term results of percutaneous mitral commissurotomy for rheumatic mitral stenosis. Circulation: Cardiovascular Interventions 7:381–389.
1.
Chopard R, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Teiger E, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Schiele F. 2014. Impact of chronic obstructive pulmonary disease on Valve Academic Research Consortium-defined outcomes after transcatheter aortic valve implantation (from the FRANCE 2 Registry). American Journal of Cardiology 113:1543–1549.
1.
Clavel M-A, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, Araoz PA, Michelena HI, Cueff C, Larose E, Miller JD, Vahanian A, Enriquez-Sarano M. 2014. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. Journal of the American College of Cardiology 64:1202–1213.
1.
Collaborative STars. 2014. Impact of postoperative non-steroidal anti-inflammatory drugs on adverse events after gastrointestinal surgery. British Journal of Surgery 101:1413–1423.
1.
Dall’Ara G, Eltchaninoff H, Moat N, Laroche C, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, Snow T, Price S, Barrero EA, Estevez-Loureiro R, Iung B, Zamorano JL, Schuler G, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Gilard M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Mattesini A, Tavazzi L, Di Mario C, Transcatheter Valve Treatment Sentinel Registry Investigators of the EurObservational Research Programme of the European Society of C. 2014. Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation. International Journal of Cardiology 177:448–454.
1.
Dreyfus J, Cimadevilla C, Nguyen V, Brochet E, Lepage L, Himbert D, Iung B, Vahanian A, Messika-Zeitoun D. 2014. Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification. European Heart Journal 35:1617–1623.
1.
Dutertre C-A, Clement M, Morvan M, Schäkel K, Castier Y, Alsac J-M, Michel J-B, Nicoletti A. 2014. Deciphering the stromal and hematopoietic cell network of the adventitia from non-aneurysmal and aneurysmal human aorta. PloS One 9:e89983.
1.
Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, Barbanti M, Latib A, Schaefer U, Rodés-Cabau J, Treede H, Piazza N, Hildick-Smith D, Himbert D, Walther T, Hengstenberg C, Nissen H, Bekeredjian R, Presbitero P, Ferrari E, Segev A, de Weger A, Windecker S, Moat NE, Napodano M, Wilbring M, Cerillo AG, Brecker S, Tchetche D, Lefèvre T, De Marco F, Fiorina C, Petronio AS, Teles RC, Testa L, Laborde J-C, Leon MB, Kornowski R, Valve-in-Valve International Data Registry I. 2014. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 312:162–170.
1.
Fassa A-A, Himbert D, Brochet E, Depoix J-P, Cheong AP, Alkhoder S, Nataf P, Vahanian A. 2014. Transseptal transcatheter mitral valve implantation for severely calcified mitral stenosis. JACC Cardiovascular interventions 7:696–697.
1.
Fassa A-A, Himbert D, Brochet E, Labbé J-P, Vahanian A. 2014. Transfemoral valve-in-ring implantation for a failing mitral homograft in the tricuspid position. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 10:269.
1.
Fassa A-A, Mazighi M, Himbert D, Deschamps L, Ducrocq G, Cheong AP, Depoix J-P, Dilly M-P, Alkhoder S, Mourvillier B, Vahanian A. 2014. Successful endovascular stroke rescue with retrieval of an embolized calcium fragment after transcatheter aortic valve replacement. Circulation: Cardiovascular Interventions 7:125–126.
1.
Feldman L, Tubach F, Juliard J-M, Himbert D, Ducrocq G, Sorbets E, Triantafyllou K, Kerner A, Abergel H, Huisse M-G, Roussel R, Esposito-Farèse M, Steg PG, Ajzenberg N. 2014. Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement. American Heart Journal 168:940–947.e5.
1.
Fontes-Carvalho R, Vahanian A. 2014. The European Society of Cardiology Webinars. European Heart Journal 35:1089–1090.
1.
Fox K, Ford I, Steg PG, Tardif J-C, Tendera M, Ferrari R, Investigators S. 2014. Ivabradine in stable coronary artery disease without clinical heart failure. New England Journal of Medicine 371:1091–1099.
1.
Gomez I, Benyahia C, Louedec L, Leséche G, Jacob M-P, Longrois D, Norel X. 2014. Decreased PGE₂ content reduces MMP-1 activity and consequently increases collagen density in human varicose vein. PloS One 9:e88021.
1.
Grube E, Sinning J-M, Vahanian A. 2014. The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions). European Heart Journal 35:490–495.
1.
Guedj K, Khallou-Laschet J, Clement M, Morvan M, Delbosc S, Gaston A-T, Andreata F, Castier Y, Deschildre C, Michel J-B, Caligiuri G, Nicoletti A. 2014. Inflammatory micro-environmental cues of human atherothrombotic arteries confer to vascular smooth muscle cells the capacity to trigger lymphoid neogenesis. PloS One 9:e116295.
1.
Guedj K, Khallou-Laschet J, Clement M, Morvan M, Gaston A-T, Fornasa G, Dai J, Gervais-Taurel M, Eberl G, Michel J-B, Caligiuri G, Nicoletti A. 2014. M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Cardiovascular Research 101:434–443.
1.
Himbert D, Bouleti C, Iung B, Nejjari M, Brochet E, Depoix J-P, Ghodbane W, Fassa A-A, Nataf P, Vahanian A. 2014. Transcatheter valve replacement in patients with severe mitral valve disease and annular calcification. Journal of the American College of Cardiology 64:2557–2558.
1.
Iung B, Erba PA, Petrosillo N, Lazzeri E. 2014. Common diagnostic flowcharts in infective endocarditis. Q J Nucl Med Mol Imaging 58:55–65.
1.
Iung B, Laouénan C, Himbert D, Eltchaninoff H, Chevreul K, Donzeau-Gouge P, Fajadet J, Leprince P, Leguerrier A, Lièvre M, Prat A, Teiger E, Laskar M, Vahanian A, Gilard M, Investigators F. 2014. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart (British Cardiac Society) 100:1016–1023.
1.
Iung B, Rodés-Cabau J. 2014. The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. European Heart Journal 35:2942–2949.
1.
Iung B, Vahanian A. 2014. Epidemiology of acquired valvular heart disease. Canadian Journal of Cardiology 30:962–970.
1.
Iung B, Vahanian A. 2014. Valvular disease: Implications of the new AHA/ACC valvular disease guidelines. Nature Reviews Cardiology 11:317–318.
1.
Iung B, Vahanian A. 2014. Lessons from the RE-ALIGN trial. Archives of Cardiovascular Diseases 107:277–279.
1.
Juillière Y, Suty-Selton C, Riant E, Darracq J-P, Dellinger A, Labarre J-P, Druelle J, Mulak G, Danchin N, Jourdain P, participants O cohort. 2014. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure. Archives of Cardiovascular Diseases 107:21–32.
1.
Klein C, Le Goff C, Topouchian V, Odent S, Violas P, Glorion C, Cormier-Daire V. 2014. Orthopedics management of acromicric dysplasia: follow up of nine patients. American Journal of Medical Genetics Part A 164A:331–337.
1.
Kota SK, Llères D, Bouschet T, Hirasawa R, Marchand A, Begon-Pescia C, Sanli I, Arnaud P, Journot L, Girardot M, Feil R. 2014. ICR noncoding RNA expression controls imprinting and DNA replication at the Dlk1-Dio3 domain. Developmental Cell 31:19–33.
1.
Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S, Ford I, Gonzalez Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Luescher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Uva MS, Voudris V, Funck-Brentano C, Authors/Task Force M. 2014. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). European Journal of Anaesthesiology 31:517–573.
1.
Lannoy M, Slove S, Jacob MP. 2014. The function of elastic fibers in the arteries: beyond elasticity. Pathol Biol 62:79–83.
1.
Lannoy M, Slove S, Louedec L, Choqueux C, Journé C, Michel J-B, Jacob M-P. 2014. Inhibition of ERK1/2 phosphorylation: a new strategy to stimulate elastogenesis in the aorta. Hypertension 64:423–430.
1.
Le Goff C, Michot C, Cormier-Daire V. 2014. Myhre syndrome. Clinical Genetics 85:503–513.
1.
Luauté J-P, Lempérière T, Arnaud P. 2014. Death of an alienist: Louis-Victor Marcé’s final year. Hist Psychiatry 25:265–282.
1.
Luçon A, Oger E, Bedossa M, Boulmier D, Verhoye JP, Eltchaninoff H, Iung B, Leguerrier A, Laskar M, Leprince P, Gilard M, Le Breton H. 2014. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry. Circulation: Cardiovascular Interventions 7:240–247.
1.
Mahr A, Batteux F, Tubiana S, Goulvestre C, Wolff M, Papo T, Vrtovsnik F, Klein I, Iung B, Duval X, Group IS. 2014. Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol 66:1672–1677.
1.
Maisano F, La Canna G, Latib A, Denti P, Taramasso M, Kuck KH, Colombo A, Alfieri O, Guidotti A, Messika-Zeitoun D, Vahanian A. 2014. First-in-man transseptal implantation of a “surgical-like” mitral valve annuloplasty device for functional mitral regurgitation. JACC Cardiovascular interventions 7:1326–1328.
1.
Marc F, Esquirol C, Papy E, Longuet P, Armand-Lefevre L, Rioux C, Diamantis S, Dumortier C, Bourgeois-Nicolaos N, Lucet JC, Wolff M, Arnaud P. 2014. A retrospective study of daptomycin use in a Paris teaching-hospital. Med Mal Infect 44:25–31.
1.
Martinez-Pinna R, Burillo E, Madrigal-Matute J, Lopez JA, Camafeita E, Torres-Fonseca MM, Llamas-Granda P, Egido J, Michel J-B, Blanco-Colio LM, Martin-Ventura JL. 2014. Label-free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients. Proteomics Clin Appl 8:626–630.
1.
Martinez-Pinna R, Lindholt JS, Madrigal-Matute J, Blanco-Colio LM, Esteban-Salan M, Torres-Fonseca MM, Lefebvre T, Delbosc S, Laustsen J, Driss F, Vega de Ceniga M, Gouya L, Weiss G, Egido J, Meilhac O, Michel JB, Martin-Ventura J. 2014. From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm. Thrombosis and Haemostasis 112:87–95.
1.
Michel J-B, Martin-Ventura JL, Nicoletti A, Ho-Tin-Noé B. 2014. Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages. Atherosclerosis 234:311–319.
1.
Michot C, Le Goff C, Mahaut C, Afenjar A, Brooks AS, Campeau PM, Destree A, Di Rocco M, Donnai D, Hennekam R, Heron D, Jacquemont S, Kannu P, Lin AE, Manouvrier-Hanu S, Mansour S, Marlin S, McGowan R, Murphy H, Raas-Rothschild A, Rio M, Simon M, Stolte-Dijkstra I, Stone JR, Sznajer Y, Tolmie J, Touraine R, van den Ende J, Van der Aa N, van Essen T, Verloes A, Munnich A, Cormier-Daire V. 2014. Myhre and LAPS syndromes: clinical and molecular review of 32 patients. European journal of human genetics 22:1272–1277.
1.
Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Lüscher TF, Moat N, Price S, Dall’Ara G, Winter R, Corti R, Grasso C, Snow TM, Jeger R, Blankenberg S, Settergren M, Tiroch K, Balzer J, Petronio AS, Büttner H-J, Ettori F, Sievert H, Fiorino MG, Claeys M, Ussia GP, Baumgartner H, Scandura S, Alamgir F, Keshavarzi F, Colombo A, Maisano F, Ebelt H, Aruta P, Lubos E, Plicht B, Schueler R, Pighi M, Di Mario C, Transcatheter Valve Treatment Sentinel Registry Investigators of the EuroRP of the ES of C. 2014. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. Journal of the American College of Cardiology 64:875–884.
1.
Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande J-L, Chopard R, Van Belle E, Otsuka T, Teiger E, Investigators FR. 2014. Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and Edwards 2 registry. Circulation: Cardiovascular Interventions 7:602–610.
1.
Porayette P, Fruitman D, Lauzon JL, Le Goff C, Cormier-Daire V, Sanders SP, Pinto-Rojas A, Perez-Atayde AR. 2014. Novel mutations in geleophysic dysplasia type 1. Pediatric and Developmental Pathology 17:209–216.
1.
Pyeritz R, Jondeau G, Moran R, De Backer J, Arbustini E, De Paepe A, Milewicz D. 2014. Loeys-Dietz syndrome is a specific phenotype and not a concomitant of any mutation in a gene involved in TGF-β signaling. Genetics in Medicine 16:641–642.
1.
Rangé H, Labreuche J, Louedec L, Rondeau P, Planesse C, Sebbag U, Bourdon E, Michel J-B, Bouchard P, Meilhac O. 2014. Periodontal bacteria in human carotid atherothrombosis as a potential trigger for neutrophil activation. Atherosclerosis 236:448–455.
1.
Regitz-Zagrosek V, Gohlke-Bärwolf C, Iung B, Pieper PG. 2014. Management of cardiovascular diseases during pregnancy. Current Problems in Cardiology 39:85–151.
1.
Rodés-Cabau J, Kahlert P, Neumann F-J, Schymik G, Webb JG, Amarenco P, Brott T, Garami Z, Gerosa G, Lefèvre T, Plicht B, Pocock SJ, Schlamann M, Thomas M, Diamond B, Merioua I, Beyersdorf F, Vahanian A. 2014. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC Cardiovascular interventions 7:1146–1155.
1.
Rossi A, Dandale R, Nistri S, Faggiano P, Cicoira M, Benfari G, Onorati F, Santini F, Messika-Zeitoun D, Enriquez-Sarano M, Vassanelli C. 2014. Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study. European Heart Journal Cardiovascular Imaging 15:631–636.
1.
Rouzet F, Chequer R, Benali K, Lepage L, Ghodbane W, Duval X, Iung B, Vahanian A, Le Guludec D, Hyafil F. 2014. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. Journal of Nuclear Medicine 55:1980–1985.
1.
Schockmel M, Agrinier N, Jourdain P, Alla F, Eicher J-C, Coulon P, Druelle J, Mulak G, Danchin N, Thilly N, Juillière Y, participants O cohort. 2014. Socioeconomic factors and mortality in diastolic heart failure. European Journal of Clinical Investigation 44:372–383.
1.
Serfaty J-M, Himbert D, Esposito-Farese M, Pasi N, Tacher V, Laissy J-P, Tubach F, Iung B, Vahanian A, Messika-Zeitoun D. 2014. Measurement of the aortic annulus diameter using transesophageal echocardiography and multislice computed tomography–are they truly comparable? Canadian Journal of Cardiology 30:1073–1079.
1.
Servy A, Valeyrie-Allanore L, Alla F, Lechiche C, Nazeyrollas P, Chidiac C, Hoen B, Chosidow O, Duval X, Association Pour l’Etude et la Prévention de l'Endocardite Infectieuse Study G. 2014. Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol 150:494–500.
1.
Tchetche D, Farah B, Misuraca L, Pierri A, Vahdat O, Lereun C, Dumonteil N, Modine T, Laskar M, Eltchaninoff H, Himbert D, Iung B, Teiger E, Chevreul K, Lievre M, Lefevre T, Donzeau-Gouge P, Gilard M, Fajadet J. 2014. Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy. JACC Cardiovascular interventions 7:1138–1145.
1.
Vahanian A. 2014. The European Heart Academy. European Heart Journal 35:3315–3316.
1.
Vahanian AP. 2014. ESC Education Committee. European Heart Journal 35:3236–3237.
1.
Vahanian A, Himbert D, Iung B. 2014. Unmet clinical needs in transcatheter mitral valve interventions in 2014. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 10 Suppl U:U101–105.
1.
Van Belle E, Juthier F, Susen S, Vincentelli A, Iung B, Dallongeville J, Eltchaninoff H, Laskar M, Leprince P, Lievre M, Banfi C, Auffray J-L, Delhaye C, Donzeau-Gouge P, Chevreul K, Fajadet J, Leguerrier A, Prat A, Gilard M, Teiger E, Investigators F. 2014. Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry. Circulation 129:1415–1427.
1.
Victorri-Vigneau C, Collin C, Messina-Gourlot C, Raffournier C, Mallaret M, Besse J, Courne M-A, Richard N, Sébille V, Arnaud P, participants of expert group of the study. 2014. Designing a tool allowing for a standardized assessment of resistance to drug diversion. Expert Opin Drug Deliv 11:995–1004.
1.
Yamamoto M, Mouillet G, Meguro K, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande J-L, Teiger E, Investigators F-R. 2014. Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry. Annals of Thoracic Surgery 97:29–36.

2013

1.
Aggarwal SR, Clavel M-A, Messika-Zeitoun D, Cueff C, Malouf J, Araoz PA, Mankad R, Michelena H, Vahanian A, Enriquez-Sarano M. 2013. Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis. Circulation: Cardiovascular Imaging 6:40–47.
1.
Al-Attar N, Himbert D, Barbier F, Vahanian A, Nataf P. 2013. Delayed aortic dissection after transcatheter aortic valve implantation. Journal of Heart Valve Disease 22:701–703.
1.
Alsac J-M, Delbosc S, Rouer M, Journé C, Louedec L, Meilhac O, Michel J-B. 2013. Fucoidan interferes with Porphyromonas gingivalis-induced aneurysm enlargement by decreasing neutrophil activation. Journal of Vascular Surgery 57:796–805.
1.
Armoiry X, Brochet E, Lefevre T, Guerin P, Dumonteil N, Himbert D, Cormier B, Piriou N, Gautier M, Messika-Zeitoun D, Romano M, Rioufol G, Warin Fresse K, Boudou N, Leclercq F, Bedossa M, Obadia J-F. 2013. Initial French experience of percutaneous mitral valve repair with the MitraClip: a multicentre national registry. Archives of Cardiovascular Diseases 106:287–294.
1.
Attias D, Macron L, Dreyfus J, Monin J-L, Brochet E, Lepage L, Hekimian G, Iung B, Vahanian A, Messika-Zeitoun D. 2013. Relationship between longitudinal strain and symptomatic status in aortic stenosis. Journal of the American Society of Echocardiography 26:868–874.
1.
Augustin P, Alsalih G, Launey Y, Delbosc S, Louedec L, Ollivier V, Chau F, Montravers P, Duval X, Michel J-B, Meilhac O. 2013. Predominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model. Infection and Immunity 81:1721–1729.
1.
Bao Dang Q, Lapergue B, Tran-Dinh A, Diallo D, Moreno J-A, Mazighi M, Romero IA, Weksler B, Michel J-B, Amarenco P, Meilhac O. 2013. High-density lipoproteins limit neutrophil-induced damage to the blood-brain barrier in vitro. Journal of Cerebral Blood Flow and Metabolism 33:575–582.
1.
Bouleti C, Iung B, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D, Garbarz E, Cormier B, Vahanian A. 2013. Long-term efficacy of percutaneous mitral commissurotomy for restenosis after previous mitral commissurotomy. Heart (British Cardiac Society) 99:1336–1341.
1.
Bouleti C, Iung B, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D, Garbarz E, Cormier B, Vahanian A. 2013. Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy. European Heart Journal 34:1923–1930.
1.
Bouleti C, Mathivet T, Coqueran B, Serfaty J-M, Lesage M, Berland E, Ardidie-Robouant C, Kauffenstein G, Henrion D, Lapergue B, Mazighi M, Duyckaerts C, Thurston G, Valenzuela DM, Murphy AJ, Yancopoulos GD, Monnot C, Margaill I, Germain S. 2013. Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke. European Heart Journal 34:3657–3668.
1.
Bruls S, Courtois A, Namur G, Smeets J-P, Nusgens BV, Michel J-B, Defraigne J-O, Sakalihasan N. 2013. Increased metabolic activity highlighted by positron emission tomography/computed tomography in the wall of the dissected ascending aorta in a patient with Horton disease. Circulation: Cardiovascular Imaging 6:606–608.
1.
Bäck M, Gasser TC, Michel J-B, Caligiuri G. 2013. Biomechanical factors in the biology of aortic wall and aortic valve diseases. Cardiovascular Research 99:232–241.
1.
Callier P, Aral B, Hanna N, Lambert S, Dindy H, Ragon C, Payet M, Collod-Beroud G, Carmignac V, Delrue MA, Goizet C, Philip N, Busa T, Dulac Y, Missotte I, Sznajer Y, Toutain A, Francannet C, Megarbane A, Julia S, Edouard T, Sarda P, Amiel J, Lyonnet S, Cormier-Daire V, Gilbert B, Jacquette A, Heron D, Collignon P, Lacombe D, Morice-Picard F, Jouk PS, Cusin V, Willems M, Sarrazin E, Amarof K, Coubes C, Addor MC, Journel H, Colin E, Khau Van Kien P, Baumann C, Leheup B, Martin-Coignard D, Doco-Fenzy M, Goldenberg A, Plessis G, Thevenon J, Pasquier L, Odent S, Vabres P, Huet F, Marle N, Mosca-Boidron AL, Mugneret F, Gauthier S, Binquet C, Thauvin-Robinet C, Jondeau G, Boileau C, Faivre L. 2013. Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability. Clinical Genetics 84:507–521.
1.
Castanares-Zapatero D, Bouleti C, Sommereyns C, Gerber B, Lecut C, Mathivet T, Horckmans M, Communi D, Foretz M, Vanoverschelde J-L, Germain S, Bertrand L, Laterre P-F, Oury C, Viollet B, Horman S, Beauloye C. 2013. Connection between cardiac vascular permeability, myocardial edema, and inflammation during sepsis: role of the α1AMP-activated protein kinase isoform. Critical Care Medicine 41:e411–422.
1.
Chevreul K, Brunn M, Cadier B, Haour G, Eltchaninoff H, Prat A, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux J-L, Pavie A, Gilard M, Gueret P, investigators F registry. 2013. Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Archives of Cardiovascular Diseases 106:209–219.
1.
Cimadevilla C, Cueff C, Hekimian G, Dehoux M, Lepage L, Iung B, Duval X, Huart V, Tubach F, Vahanian A, Messika-Zeitoun D. 2013. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study. Heart (British Cardiac Society) 99:461–467.
1.
Clavel M-A, Messika-Zeitoun D, Pibarot P, Aggarwal SR, Malouf J, Araoz PA, Michelena HI, Cueff C, Larose E, Capoulade R, Vahanian A, Enriquez-Sarano M. 2013. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. Journal of the American College of Cardiology 62:2329–2338.
1.
Courtois A, Nusgens BV, Hustinx R, Namur G, Gomez P, Somja J, Defraigne J-O, Delvenne P, Michel J-B, Colige AC, Sakalihasan N. 2013. 18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. Journal of Nuclear Medicine 54:1740–1747.
1.
Dallaudière B, Lempicki M, Pesquer L, Louedec L, Preux PM, Meyer P, Hess A, Durieux MHM, Hummel V, Larbi A, Deschamps L, Benayoun Y, Journe C, Perozziello A, Schouman-Claeys E, Michel JB, Serfaty JM. 2013. Acceleration of tendon healing using US guided intratendinous injection of bevacizumab: first pre-clinical study on a murine model. European Journal of Radiology 82:e823–828.
1.
Dallaudière B, Lempicki M, Pesquer L, Louedec L, Preux PM, Meyer P, Hummel V, Larbi A, Deschamps L, Journe C, Hess A, Silvestre A, Sargos P, Loriaut P, Boyer P, Schouman-Claeys E, Michel JB, Serfaty JM. 2013. Efficacy of intra-tendinous injection of platelet-rich plasma in treating tendinosis: comprehensive assessment of a rat model. European Radiology 23:2830–2837.
1.
Delbosc S, Diallo D, Dejouvencel T, Lamiral Z, Louedec L, Martin-Ventura J-L, Rossignol P, Leseche G, Michel J-B, Meilhac O. 2013. Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm. Cardiovascular Research 100:307–315.
1.
Descoutures F, Himbert D, Maisano F, Casselman F, de Weger A, Bodea O, Van der Kley F, Colombo A, Giannini C, Rein KA, De Bruyne B, Petronio AS, Dahle G, Alfieri O, Vahanian A. 2013. Transcatheter valve-in-ring implantation after failure of surgical mitral repair. European Journal of Cardio-Thoracic Surgery 44:e8–15.
1.
Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, Alegria Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Gilard M, Witowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L, Transcatheter Valve Treatment Sentinel Registry Investigators of the EuroRP of the ES of C. 2013. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 8:1362–1371.
1.
Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt J-U, Simoons ML, Van de Werf F, Investigators R-A. 2013. Dabigatran versus warfarin in patients with mechanical heart valves. New England Journal of Medicine 369:1206–1214.
1.
Fassa A-A, Himbert D, Brochet E, Alkhoder S, Al-Attar N, Brun P-Y, Wolff M, Nataf P, Vahanian A. 2013. Emergency transseptal transcatheter mitral valve-in-valve implantation. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 9:636–642.
1.
Fassa A-A, Himbert D, Vahanian A. 2013. Mechanisms and management of TAVR-related complications. Nature Reviews Cardiology 10:685–695.
1.
Fassa A-A, Himbert D, Vahanian A. 2013. Transcatheter aortic valve replacement: current application and future directions. Current Cardiology Reports 15:353.
1.
Gomez D, Kessler K, Michel J-B, Vranckx R. 2013. Modifications of chromatin dynamics control Smad2 pathway activation in aneurysmal smooth muscle cells. Circulation Research 113:881–890.
1.
Goulenok T, Klein I, Mazighi M, Messika-Zeitoun D, Alexandra JF, Mourvillier B, Laissy JP, Leport C, Iung B, Duval X, group I study. 2013. Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging. Cerebrovascular Diseases 35:327–336.
1.
Guidoux C, Mazighi M, Lavallée P, Labreuche J, Meseguer E, Cabrejo L, Messika-Zeitoun D, Escoubet B, Touboul P-J, Steg PG, Amarenco P. 2013. Aortic arch atheroma in transient ischemic attack patients. Atherosclerosis 231:124–128.
1.
Hekimian G, Boutten A, Flamant M, Duval X, Dehoux M, Benessiano J, Huart V, Dupré T, Berjeb N, Tubach F, Iung B, Vahanian A, Messika-Zeitoun D. 2013. Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients–the COFRASA study. European Heart Journal 34:1915–1922.
1.
Hess A, Klein I, Iung B, Lavallée P, Ilic-Habensus E, Dornic Q, Arnoult F, Mimoun L, Wolff M, Duval X, Laissy JP. 2013. Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR 34:1579–1584.
1.
Hyafil F, Rouzet F, Lepage L, Benali K, Raffoul R, Duval X, Hvass U, Iung B, Nataf P, Lebtahi R, Vahanian A, Le Guludec D. 2013. Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography. European Heart Journal Cardiovascular Imaging 14:586–594.
1.
Iung B, Tubiana S, Klein I, Messika-Zeitoun D, Brochet E, Lepage L, Al-Attar N, Ruimy R, Leport C, Wolff M, Duval X, Group E-IS. 2013. Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study. Stroke 44:3056–3062.
1.
Iung B, Vahanian A. 2013. Towards improved risk scores: the quest for the grail continues. European Heart Journal 34:10–12.
1.
Juliard J-M, Golmard JL, Himbert D, Feldman LJ, Delorme L, Ducrocq G, Descoutures F, Sorbets E, Garbarz E, Boudvillain O, Aubry P, Vahanian A, Steg PG. 2013. Comparison of hospital mortality during ST-segment elevation myocardial infarction in the era of reperfusion therapy in women versus men and in older versus younger patients. American Journal of Cardiology 111:1708–1713.
1.
Khelaifia S, Brunel JM, Michel JB, Drancourt M. 2013. In-vitro archaeacidal activity of biocides against human-associated archaea. PloS One 8:e62738.
1.
Kochtebane N, Passefort S, Choqueux C, Ainoun F, Achour L, Michel J-B, Bäck M, Jacob M-P. 2013. Release of leukotriene B4, transforming growth factor-beta1 and microparticles in relation to aortic valve calcification. Journal of Heart Valve Disease 22:782–788.
1.
Krapf L, Dreyfus J, Cueff C, Lepage L, Brochet E, Vahanian A, Messika-Zeitoun D. 2013. Anatomical features of rheumatic and non-rheumatic mitral stenosis: potential additional value of three-dimensional echocardiography. Archives of Cardiovascular Diseases 106:111–115.
1.
Kuivaniemi H, Sakalihasan N, Lederle FA, Jones GT, Defraigne J-O, Labropoulos N, Legrand V, Michel J-B, Nienaber C, Radermecker MA, Elefteriades JA. 2013. New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3). Aorta 1:23–39.
1.
Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, Donal E, Prendergast B, Magne J, La Canna G, Piérard LA, Maurer G. 2013. ESC Working Group on Valvular Heart Disease position paper–heart valve clinics: organization, structure, and experiences. European Heart Journal 34:1597–1606.
1.
Lapergue B, Dang BQ, Desilles J-P, Ortiz-Munoz G, Delbosc S, Loyau S, Louedec L, Couraud P-O, Mazighi M, Michel J-B, Meilhac O, Amarenco P. 2013. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke. Stroke 44:699–707.
1.
Latib A, Messika-Zeitoun D, Maisano F, Himbert D, Agricola E, Brochet E, Alfieri O, Colombo A, Vahanian A. 2013. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. Journal of the American College of Cardiology 61:787–789.
1.
Le Goff C, Mahaut C, Bottani A, Doray B, Goldenberg A, Moncla A, Odent S, Nitschke P, Munnich A, Faivre L, Cormier-Daire V. 2013. Not all floating-harbor syndrome cases are due to mutations in exon 34 of SRCAP. Human Mutation 34:88–92.
1.
Lilly SM, Rome J, Anwaruddin S, Shreenivas S, Desai N, Silvestry FE, Herrmann HC, Fassa A, Himbert D, Brochet E, Labbé J-P, Depoix J-P, Hvass U, Vahanian A, Holoshitz N, Kenny D, Hijazi ZM. 2013. How should I treat prosthetic tricuspid stenosis in an extreme surgical risk patient? EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 9:407–409.
1.
Lindholt JS, Björck M, Michel JB. 2013. Anti-platelet treatment of middle-sized abdominal aortic aneurysms. Current Vascular Pharmacology 11:305–313.
1.
Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, Amir O, Chioncel O, Leiro MC, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Persson H, Seferovic P, Temizhan A, Tousoulis D, Tavazzi L, Heart Failure Association of the ESC. 2013. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. European Journal of Heart Failure 15:1173–1184.
1.
Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L, Heart Failure Association of the European Society of C. 2013. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). European Journal of Heart Failure 15:808–817.
1.
Martinez-Pinna R, Lopez JA, Ramos-Mozo P, Blanco-Colio LM, Camafeita E, Calvo E, Meilhac O, Michel JB, Egido J, Martin-Ventura JL. 2013. Identification of novel biomarkers of abdominal aortic aneurysms by 2D-DIGE and MALDI-MS from AAA-thrombus-conditioned media. Methods in Molecular Biology 1000:91–101.
1.
Martinez-Pinna R, Madrigal-Matute J, Tarin C, Burillo E, Esteban-Salan M, Pastor-Vargas C, Lindholt JS, Lopez JA, Calvo E, de Ceniga MV, Meilhac O, Egido J, Blanco-Colio LM, Michel J-B, Martin-Ventura JL. 2013. Proteomic analysis of intraluminal thrombus highlights complement activation in human abdominal aortic aneurysms. Arteriosclerosis, Thrombosis, and Vascular Biology 33:2013–2020.
1.
Messika-Zeitoun D. 2013. Percutaneous mitral valve repair using the MitraClip system: time to move forward. Heart (British Cardiac Society) 99:975–976.
1.
Messika-Zeitoun D, Topilsky Y, Enriquez-Sarano M. 2013. The role of echocardiography in the management of patients with myxomatous disease. Cardiology Clinics 31:217–229.
1.
Michel J-B, Rouer M, Alsac J-M. 2013. Regarding “A multilayer stent in the aorta may not seal the aneurysm, thereby leading to rupture.” Journal of Vascular Surgery 57:605.
1.
Michelena HI, Margaryan E, Miller FA, Eleid M, Maalouf J, Suri R, Messika-Zeitoun D, Pellikka PA, Enriquez-Sarano M. 2013. Inconsistent echocardiographic grading of aortic stenosis: is the left ventricular outflow tract important? Heart (British Cardiac Society) 99:921–931.
1.
Moubarak G, Bonhomme S, Vedrenne G, Bouleti C, Ollitrault J, Priollet P, Cador R, Cazeau S. 2013. Femoral vein thrombosis after right-sided electrophysiological procedures. Journal of Interventional Cardiac Electrophysiology 38:155–158.
1.
Nicoletti A, Khallou-Laschet J, Guedj K, Clement M, Gaston A-T, Morvan M, Dutertre C-A, Michel J-B, Thaunat O, Caligiuri G. 2013. L19. Lymphoid neogenesis in vascular chronic inflammation. Presse Medicale 42:558–560.
1.
Pommier AJC, Dufour J, Alves G, Viennois E, De Boussac H, Trousson A, Volle DH, Caira F, Val P, Arnaud P, Lobaccaro J-MA, Baron S. 2013. Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice. PLoS Genet 9:e1003483.
1.
Roos-Hesselink JW, Ruys TPE, Stein JI, Thilén U, Webb GD, Niwa K, Kaemmerer H, Baumgartner H, Budts W, Maggioni AP, Tavazzi L, Taha N, Johnson MR, Hall R, Investigators R. 2013. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. European Heart Journal 34:657–665.
1.
Rouchaud A, Journé C, Louedec L, Ollivier V, Derkaoui M, Michel J-B, Mazighi M. 2013. Autologous mesenchymal stem cell endografting in experimental cerebrovascular aneurysms. Neuroradiology 55:741–749.
1.
Rouer M, Meilhac O, Delbosc S, Louedec L, Pavon-Djavid G, Cross J, Legagneux J, Bouilliant-Linet M, Michel J-B, Alsac J-M. 2013. A new murine model of endovascular aortic aneurysm repair. J Vis Exp e50740.
1.
Siam-Tsieu V, Cueff C, Messika-Zeitoun D. 2013. Early mitral valve surgery two days after an ischaemic embolic stroke. Archives of Cardiovascular Diseases 106:549–550.
1.
Slove S, Lannoy M, Behmoaras J, Pezet M, Sloboda N, Lacolley P, Escoubet B, Buján J, Jacob M-P. 2013. Potassium channel openers increase aortic elastic fiber formation and reverse the genetically determined elastin deficit in the BN rat. Hypertension 62:794–801.
1.
Sordi M, Brochet E, Messika-Zeitoun D. 2013. Mitral paravalvular leak detected by three-dimensional transoesophageal echocardiography. Archives of Cardiovascular Diseases 106:627–628.
1.
Spagnoli V, Attias D, Vahanian A. 2013. A rare cause of persistent fever in pulmonary homograft endocarditis. Heart Asia 5:225.
1.
Tran-Dinh A, Diallo D, Delbosc S, Varela-Perez LM, Dang QB, Lapergue B, Burillo E, Michel JB, Levoye A, Martin-Ventura JL, Meilhac O. 2013. HDL and endothelial protection. British Journal of Pharmacology 169:493–511.
1.
Vahanian A, Alfieri O. 2013. Guidelines on valvular heart disease in clinical practice. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 9 Suppl:S11–13.
1.
Vahanian A, Iung B, Himbert D. 2013. Transcatheter aortic valve implantation: a treatment we are going to need! Journal of the American College of Cardiology 62:1013–1014.
1.
Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino P, Thomas M, investigators S. 2013. Transapical aortic valve implantation: mid-term outcome from the SOURCE registry. European Journal of Cardio-Thoracic Surgery 43:505–511; discussion 511–512.
1.
Yamamoto M, Mouillet G, Oguri A, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande J-L, Teiger E, Investigators FR. 2013. Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry). American Journal of Cardiology 112:1932–1937.
1.
Zayani Y, Allal-Elasmi M, Jacob MP, Zidi W, Zaroui A, Feki M, Mourali S, Mechmech R, Kaabachi N. 2013. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes. Clinical Laboratory 59:169–175.
1.
Zeggwagh NA, Michel JB, Eddouks M. 2013. Vascular effects of aqueous extract of Chamaemelum nobile: in vitro pharmacological studies in rats. Clinical and Experimental Hypertension 35:200–206.

2012

1.
Abifadel M, Guerin M, Benjannet S, Rabès J-P, Le Goff W, Julia Z, Hamelin J, Carreau V, Varret M, Bruckert E, Tosolini L, Meilhac O, Couvert P, Bonnefont-Rousselot D, Chapman J, Carrié A, Michel J-B, Prat A, Seidah NG, Boileau C. 2012. Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia. Atherosclerosis 223:394–400.
1.
Al-Salih G, Al-Attar N, Delbosc S, Louedec L, Corvazier E, Loyau S, Michel J-B, Pidard D, Duval X, Meilhac O. 2012. Role of vegetation-associated protease activity in valve destruction in human infective endocarditis. PloS One 7:e45695.
1.
Annane D, Antona M, Lehmann B, Kedzia C, Chevret S, Investigators C, Crics, Azurea, networks RS. 2012. Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemic. Intensive Care Medicine 38:29–39.
1.
Attias D, Bouleti C, Vahanian A. 2012. Persistent fever in a multicomplicated infective endocarditis. Archives of Cardiovascular Diseases 105:535–536.
1.
Avouac J, Meune C, Ruiz B, Couraud PO, Uzan G, Boileau C, Kahan A, Chiocchia G, Allanore Y. 2012. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis. Annals of the Rheumatic Diseases 71:394–399.
1.
Boileau C, Guo DC, Hanna N, Regalado ES, Detaint D, Gong L, Varret M, Prakash SK, Li AH, d’Indy H, Braverman AC, Grandchamp B, Kwartler CS, Gouya L, Santos-Cortez RL, Abifadel M, Leal SM, Muti C, Shendure J, Gross MS, Rieder MJ, Vahanian A, Nickerson DA, Michel JB, National Heart L, Blood Institute Go Exome Sequencing P, Jondeau G, Milewicz DM. 2012. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 44:916–21.
1.
Boukantar M, Cueff C, Brochet E, Vahanian A, Messika Zeitoun D. 2012. Transoesophageal echocardiography: an unusual trigger to Takotsubo cardiomyopathy. European Heart Journal Cardiovascular Imaging 13:445.
1.
Bouleti C, Iung B, Laouénan C, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D, Garbarz E, Cormier B, Michel P-L, Mentré F, Vahanian A. 2012. Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation 125:2119–2127.
1.
Bouton M-C, Boulaftali Y, Richard B, Arocas V, Michel J-B, Jandrot-Perrus M. 2012. Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology. Blood 119:2452–2457.
1.
Calvert PA, Himbert D, Brochet E, Radu C, Iung B, Hvass U, Darondel J-M, Depoix J-P, Nataf P, Vahanian A. 2012. Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 7:1336–1339.
1.
Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Guidelines ESCC for P. 2012. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. European Heart Journal 33:2719–2747.
1.
Castaigne S, Pautas C, Terré C, Raffoux E, Bordessoule D, Bastie J-N, Legrand O, Thomas X, Turlure P, Reman O, de Revel T, Gastaud L, de Gunzburg N, Contentin N, Henry E, Marolleau J-P, Aljijakli A, Rousselot P, Fenaux P, Preudhomme C, Chevret S, Dombret H, Acute Leukemia French A. 2012. Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study. Lancet 379:1508–1516.
1.
Chiampan A, Nahum J, Leye M, Oziel J, Cueff C, Brochet E, Iung B, Rossi A, Vahanian A, Messika-Zeitoun D. 2012. Determinants of regurgitant volume in mitral regurgitation: contrasting effect of similar effective regurgitant orifice area in functional and organic mitral regurgitation. European Heart Journal Cardiovascular Imaging 13:324–329.
1.
Clauser S, Meilhac O, Bièche I, Raynal P, Bruneval P, Michel J-B, Borgel D. 2012. Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques. Thrombosis and Haemostasis 107:140–149.
1.
Coron F, Rousseau T, Jondeau G, Gautier E, Binquet C, Gouya L, Cusin V, Odent S, Dulac Y, Plauchu H, Collignon P, Delrue MA, Leheup B, Joly L, Huet F, Thevenon J, Mace G, Cassini C, Thauvin-Robinet C, Wolf JE, Hanna N, Sagot P, Boileau C, Faivre L. 2012. What do French patients and geneticists think about prenatal and preimplantation diagnoses in Marfan syndrome? Prenatal Diagnosis 32:1318–1323.
1.
Cueff C, Keenan NG, Krapf L, Steg PG, Cimadevilla C, Ducrocq G, Michel J-B, Vahanian A, Messika-Zeitoun D. 2012. Screening for abdominal aortic aneurysm in coronary care unit patients with acute myocardial infarction using portable transthoracic echocardiography. European Heart Journal Cardiovascular Imaging 13:574–578.
1.
Di Filippo M, Créhalet H, Samson-Bouma ME, Bonnet V, Aggerbeck LP, Rabès J-P, Gottrand F, Luc G, Bozon D, Sassolas A. 2012. Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia. Journal of Lipid Research 53:548–555.
1.
Donadille B, Rousseau A, Zenaty D, Cabrol S, Courtillot C, Samara-Boustani D, Salenave S, Monnier-Cholley L, Meuleman C, Jondeau G, Iserin L, Duranteau L, Cabanes L, Bourcigaux N, Bonnet D, Bouchard P, Chanson P, Polak M, Touraine P, Lebouc Y, Carel J-C, Léger J, Christin-Maitre S. 2012. Cardiovascular findings and management in Turner syndrome: insights from a French cohort. European Journal of Endocrinology 167:517–522.
1.
Ducrocq G, Al-Attar N, Himbert D, Messika-Zeitoun D, Iung B, Descoutures F, Nataf P, Vahanian A. 2012. Early and mid-term outcomes in patients undergoing transcatheter aortic valve implantation after previous coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery 41:499–504.
1.
Duval X, Delahaye F, Alla F, Tattevin P, Obadia J-F, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B, Group AS. 2012. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. Journal of the American College of Cardiology 59:1968–1976.
1.
Dvir D, Lavi I, Eltchaninoff H, Himbert D, Almagor Y, Descoutures F, Vahanian A, Tron C, Cribier A, Kornowski R. 2012. Multicenter evaluation of Edwards SAPIEN positioning during transcatheter aortic valve implantation with correlates for device movement during final deployment. JACC Cardiovascular interventions 5:563–570.
1.
Fifth Joint Task Force of the European Society of C, European Association of E, European Association of Percutaneous Cardiovascular I, European Heart Rhythm A, Heart Failure A, European Association for Cardiovascular P, Rehabilitation, European Atherosclerosis S, International Society of Behavioural M, European Stroke O, European Society of H, European Association for the Study of D, European Society of General Practice/Family M, International Diabetes Federation E, European Heart N. 2012. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 19:585–667.
1.
Fornasa G, Clement M, Groyer E, Gaston A-T, Khallou-Laschet J, Morvan M, Guedj K, Kaveri SV, Tedgui A, Michel J-B, Nicoletti A, Caligiuri G. 2012. A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovascular Research 94:30–37.
1.
Fritze O, Romero B, Schleicher M, Jacob MP, Oh D-Y, Starcher B, Schenke-Layland K, Bujan J, Stock UA. 2012. Age-related changes in the elastic tissue of the human aorta. Journal of Vascular Research 49:77–86.
1.
Galaup A, Gomez E, Souktani R, Durand M, Cazes A, Monnot C, Teillon J, Le Jan S, Bouleti C, Briois G, Philippe J, Pons S, Martin V, Assaly R, Bonnin P, Ratajczak P, Janin A, Thurston G, Valenzuela DM, Murphy AJ, Yancopoulos GD, Tissier R, Berdeaux A, Ghaleh B, Germain S. 2012. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 125:140–149.
1.
Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel J-P, Bourlon F, Bertrand B, Van Belle E, Laskar M, Investigators F. 2012. Registry of transcatheter aortic-valve implantation in high-risk patients. New England Journal of Medicine 366:1705–1715.
1.
Hekimian G, Detaint D, Messika-Zeitoun D, Attias D, Iung B, Himbert D, Brochet E, Vahanian A. 2012. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. Journal of the American Society of Echocardiography 25:160–165.
1.
Henckel A, Chebli K, Kota SK, Arnaud P, Feil R. 2012. Transcription and histone methylation changes correlate with imprint acquisition in male germ cells. EMBO journal 31:606–615.
1.
Himbert D, Descoutures F, Brochet E, Iung B, Détaint D, Messika-Zeitoun D, Alkhoder S, Mimoun L, Sordi M, Depoix J-P, Ducrocq G, Nataf P, Vahanian A. 2012. Transvenous mitral valve replacement after failure of surgical ring annuloplasty. Journal of the American College of Cardiology 60:1205–1206.
1.
Himbert D, Pontnau F, Messika-Zeitoun D, Descoutures F, Détaint D, Cueff C, Sordi M, Laissy J-P, Alkhoder S, Brochet E, Iung B, Depoix J-P, Nataf P, Vahanian A. 2012. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. American Journal of Cardiology 110:877–883.
1.
Hyafil F, Messika-Zeitoun D, Burg S, Rouzet F, Benali K, Iung B, Vahanian A, Le Guludec D. 2012. Detection of 18fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. American Journal of Cardiology 109:1194–1196.
1.
Iglesias-Platas I, Martin-Trujillo A, Cirillo D, Court F, Guillaumet-Adkins A, Camprubi C, Bourc’his D, Hata K, Feil R, Tartaglia G, Arnaud P, Monk D. 2012. Characterization of novel paternal ncRNAs at the Plagl1 locus, including Hymai, predicted to interact with regulators of active chromatin. PloS One 7:e38907.
1.
Iung B. 2012. Heart disease in pregnant women: recent ESC guidelines. Archives of Cardiovascular Diseases 105:57–59.
1.
Iung B, Himbert D, Vahanian A. 2012. Atrial fibrillation following transcatheter aortic valve implantation: do we underestimate its frequency and impact? Journal of the American College of Cardiology 59:189–190.
1.
Iung B, Klein I, Mourvillier B, Olivot J-M, Détaint D, Longuet P, Ruimy R, Fourchy D, Laurichesse J-J, Laissy J-P, Escoubet B, Duval X, Study G. 2012. Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis. European Heart Journal Cardiovascular Imaging 13:703–710.
1.
Iung B, Vahanian A. 2012. Degenerative calcific aortic stenosis: a natural history. Heart (British Cardiac Society) 98 Suppl 4:iv7–13.
1.
Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers H-J, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. 2012. Guidelines on the management of valvular heart disease (version 2012). European Heart Journal 33:2451–2496.
1.
Keenan NG, Brochet É, Juliard J-M, Malanca M, Aubry P, Lepage L, Cueff C, Jondeau G, Iung B, Vahanian A, Messika-Zeitoun D. 2012. Aortic root dilatation in young patients with cryptogenic stroke and patent foramen ovale. Archives of Cardiovascular Diseases 105:13–17.
1.
Lacolley P, Regnault V, Nicoletti A, Li Z, Michel J-B. 2012. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovascular Research 95:194–204.
1.
Le Goff C, Cormier-Daire V. 2012. From tall to short: the role of TGFβ signaling in growth and its disorders. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 160C:145–153.
1.
Le Visage C, Gournay O, Benguirat N, Hamidi S, Chaussumier L, Mougenot N, Flanders JA, Isnard R, Michel J-B, Hatem S, Letourneur D, Norol F. 2012. Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection. Tissue Eng Part A 18:35–44.
1.
Lepage L, Krapf L, Hekimian G, Duval X, Nataf P, Hvass U, Vahanian A, Messika-Zeitoun D. 2012. Unusual presentation of cryolife O’Brien(R) stentless aortic valve bioprosthesis dysfunction mimicking infective endocarditis. European Journal of Cardio-Thoracic Surgery 41:800–805.
1.
Martin-Ventura JL, Madrigal-Matute J, Martinez-Pinna R, Ramos-Mozo P, Blanco-Colio LM, Moreno JA, Tarin C, Burillo E, Fernandez-Garcia CE, Egido J, Meilhac O, Michel J-B. 2012. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options. Thrombosis and Haemostasis 108:435–442.
1.
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the D, Treatment of A, Chronic Heart Failure of the European Society of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, Guidelines ESCC for P. 2012. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure 14:803–869.
1.
Michel J-B, Delbosc S, Ho-Tin-Noé B, Leseche G, Nicoletti A, Meilhac O, Martin-Ventura JL. 2012. From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages. Journal of Cardiovascular Medicine 13:628–634.
1.
Michel J-B, Li Z, Lacolley P. 2012. Smooth muscle cells and vascular diseases. Cardiovascular Research 95:135–137.
1.
Michot C, Le Goff C, Goldenberg A, Abhyankar A, Klein C, Kinning E, Guerrot A-M, Flahaut P, Duncombe A, Baujat G, Lyonnet S, Thalassinos C, Nitschke P, Casanova J-L, Le Merrer M, Munnich A, Cormier-Daire V. 2012. Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis. American Journal of Human Genetics 90:740–745.
1.
Moreno JA, Ortega-Gómez A, Delbosc S, Beaufort N, Sorbets E, Louedec L, Esposito-Farèse M, Tubach F, Nicoletti A, Steg PG, Michel J-B, Feldman L, Meilhac O. 2012. In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis. European Heart Journal 33:252–263.
1.
Moubarak G, Pavin D, Behar N, Martins RP, Bouleti C, Leclercq C, Daubert J-C, Mabo P. 2012. Relationship between Holter findings immediately after ablation of typical atrial flutter and subsequent risk of atrial fibrillation. International Journal of Cardiology 157:271–272.
1.
Naber CK, Prendergast B, Thomas M, Vahanian A, Iung B, Rosenhek R, Tornos P, Otto CM, Antunes MJ, Kappetein P, Lange R, Wendler O. 2012. An interdisciplinary debate initiated by the European Society of Cardiology Working Group on Valvular Heart Disease. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 7:1257–1274.
1.
Nizon M, Huber C, De Leonardis F, Merrina R, Forlino A, Fradin M, Tuysuz B, Abu-Libdeh BY, Alanay Y, Albrecht B, Al-Gazali L, Basaran SY, Clayton-Smith J, Désir J, Gill H, Greally MT, Koparir E, van Maarle MC, MacKay S, Mortier G, Morton J, Sillence D, Vilain C, Young I, Zerres K, Le Merrer M, Munnich A, Le Goff C, Rossi A, Cormier-Daire V. 2012. Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. Human Mutation 33:1261–1266.
1.
Obadia J-F, Iung B, Maisano F. 2012. Treatment of mitral regurgitation: from sternotomy to percutaneous approach–a paradigm shift? Archives of Cardiovascular Diseases 105:401–403.
1.
Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel J-B, Corot C, Ballet S. 2012. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging. Molecular Pharmaceutics 9:850–861.
1.
Radu C, Raffoul R, Brochet E, Himbert D. 2012. Delayed migration of a transfemorally implanted aortic bioprosthesis. Journal of Thoracic and Cardiovascular Surgery 143:e1–3.
1.
Ragelle H, Crauste-Manciet S, Seguin J, Brossard D, Scherman D, Arnaud P, Chabot GG. 2012. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice. International Journal of Pharmaceutics 427:452–459.
1.
Ramos-Mozo P, Madrigal-Matute J, Vega de Ceniga M, Blanco-Colio LM, Meilhac O, Feldman L, Michel J-B, Clancy P, Golledge J, Norman PE, Egido J, Martin-Ventura JL. 2012. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis 220:552–556.
1.
Ramos-Mozo P, Rodriguez C, Pastor-Vargas C, Blanco-Colio LM, Martinez-Gonzalez J, Meilhac O, Michel JB, Vega de Ceniga M, Egido J, Martin-Ventura JL. 2012. Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm. Atherosclerosis 221:544–550.
1.
Sarda-Mantel L, Alsac J-M, Boisgard R, Hervatin F, Montravers F, Tavitian B, Michel J-B, Le Guludec D. 2012. Comparison of 18F-fluoro-deoxy-glucose, 18F-fluoro-methyl-choline, and 18F-DPA714 for positron-emission tomography imaging of leukocyte accumulation in the aortic wall of experimental abdominal aneurysms. Journal of Vascular Surgery 56:765–773.
1.
Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B, Group AS. 2012. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clinical Infectious Diseases 54:1230–1239.
1.
Task Force on the management of ST segment elevation acute myocardial infarction of the ES of C, Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van ’t Hof A, Widimsky P, Zahger D. 2012. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal 33:2569–2619.
1.
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESCAAHAWHFTF for UD of MI, Authors/Task Force Members C, Thygesen K, Alpert JS, White HD, Biomarker S, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Subcommittee ECG, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Imaging S, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Classification S, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Intervention S, Uretsky BF, Steg PG, Wijns W, Bassand J-P, Menasche P, Ravkilde J, Trials, Registries S, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Trials, Registries S, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Trials, Registries S, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Trials, Registries S, Smith SC, Hu D, Lopez-Sendon J-L, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Guidelines ESCC for P, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Document R, Morais J, Aguiar C, Almahmeed W, others. 2012. Third universal definition of myocardial infarction. Journal of the American College of Cardiology 60:1581–1598.
1.
Vahanian A, Himbert D, Brochet E, Depoix J-P, Iung B, Nataf P. 2012. Transcatheter aortic valve implantation: our vision of the future. Archives of Cardiovascular Diseases 105:181–186.
1.
Vahanian A, Iung B. 2012. The new ESC/EACTS guidelines on the management of valvular heart disease. Archives of Cardiovascular Diseases 105:465–467.
1.
Van Mieghem NM, Tchetche D, Chieffo A, Dumonteil N, Messika-Zeitoun D, van der Boon RMA, Vahdat O, Buchanan GL, Marcheix B, Himbert D, Serruys PW, Fajadet J, Colombo A, Carrié D, Vahanian A, de Jaegere PPT. 2012. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. American Journal of Cardiology 110:1361–1367.
1.
Zayani Y, Allal-Elasmi M, Jacob MP, Zidi W, Ftouhi B, Feki M, Slimane H, Kaabachi N. 2012. Abnormal circulating levels of matrix metalloproteinases and their inhibitors in diabetes mellitus. Clinical Laboratory 58:779–785.

One thought on “Team 2: Cardiovascular Structural Diseases

  1. Pingback: The PCSK9 story

Comments are closed.